School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Dong Shin MD

  • Department of Hematology and Medical Oncology
    Professor
  • (404) 778-2980
  • dmshin@emory.edu
Head shot of Dong Shin

Academic Appointment

  • Adjunct Professor, The Wallace Coulter Department of Biomedical Engineering, Emory University & Georgia Institute of Technology
  • Professor (tenured), Hematology and Medical Oncology, Emory University School of Medicine
  • Professor, Otolaryngology, Emory University School of Medicine

Education

Degrees

  • MD from Yonsei University
  • Pre-Med from Yonsei University

Research

Focus

  • Head and neck cancer and lung cancer that I treat, study, and research account for 25% of all cancer related deaths in the United States. Over the last 20 years, my research has focused on the following areas, and my research focus will continue in the: 1. Establishment of a carcinogenesis model in preclinical and clinical settings for head and neck cancer and lung cancer; 2. Development of biomarkers in animal and human carcinogenesis for head and neck cancer and lung cancer.

Publications

  • Early-phase trial of IAP antagonist tolinapant and definitive radiation in cisplatin-ineligible patients with advanced head and neck cancer.
    Clin Cancer Res
    05/12/2025 Authors: Schmitt NC; Stokes WA; Bates JE; Kinney BLC; Remick J; McDonald MW; Rudra S; Steininger M; Oyewole M; Patel MR
  • Prospective Pilot Study of Second Primary Tumor Prevention With Erlotinib and Celecoxib in Early-Stage Squamous Cell Carcinoma of the Head and Neck: Long-Term Follow-Up.
    Head Neck
    04/28/2025 Authors: Kim P; Saba NF; McCook-Veal A; Liu Y; Klein AM; Beitler JJ; Chen A; Khuri FR; Shin DM
  • Neoadjuvant chemotherapy and surgery versus surgery for organ preservation of T3 and T4a nasal and paranasal sinus squamous cell carcinoma (NPNSCC) ECOG-ACRIN EA3163.
    Clin Cancer Res
    04/14/2025 Authors: Saba NF; Flamand Y; Lin DT; Chung CH; McDonald MW; Flampouri S; Khan SA; Snyderman CH; Hanna EY; El-Sayed IH
  • A Revised Optical Coherence Tomography-Derived Calcium Score to Predict Stent Underexpansion in SeverelyCalcified Lesions.
    JACC Cardiovasc Interv Volume: 18 Page(s): 622 - 633
    03/10/2025 Authors: Sato T; Matsumura M; Yamamoto K; Sugizaki Y; Shlofmitz E; Moses JW; Khalique OK; Thomas SV; Malik S; Dakroub A
  • Microvascular Resistance Reserve and Prognosis After Heart Transplantation.
    JACC Cardiovasc Interv Volume: 18 Page(s): 439 - 452
    02/24/2025 Authors: Ha J; Lee SH; Choi K-H; Shin D; Hong D; Kim D; Yang JH; Cho YH; Sung K; Park M
  • Diagnostic Performance and Clinical Impact of Photon-Counting Detector Computed Tomography in Coronary Artery Disease.
    J Am Coll Cardiol Volume: 85 Page(s): 339 - 348
    02/04/2025 Authors: Sakai K; Shin D; Singh M; Malik S; Dakroub A; Sami Z; Weber J; Cao JJ; Parikh R; Chen L
  • Outcomes of intravascular imaging-guided percutaneous coronary intervention according to lesion complexity.
    EuroIntervention Volume: 21 Page(s): e171 - e182
    02/03/2025 Authors: Lee SY; Lee S-J; Kwon W; Lee SH; Shin D; Lee SY; Kim SM; Yun KH; Cho JY; Kim CJ
  • Coronary artery disease and percutaneous coronary intervention in patients with severe chronic kidney disease.
    Prog Cardiovasc Dis Volume: 88 Page(s): 75 - 79
    01/01/2025 Authors: Shin D; Galougahi KK; Singh M; Caron E; Cannata M; Ciftcikal Y; Gujja M; Sakai K; Moses J; Shlofmitz R
  • DNA methylation profiles of cancer-related fatigue associated with markers of inflammation and immunometabolism.
    Mol Psychiatry Volume: 30 Page(s): 76 - 83
    01/01/2025 Authors: Xiao C; Peng G; Conneely KN; Zhao H; Felger JC; Wommack EC; Higgins KA; Shin DM; Saba NF; Bruner DW
  • Outcomes of coronary intravascular lithotripsy for the treatment of calcified nodules: a pooled analysis of the Disrupt CAD studies.
    EuroIntervention Volume: 20 Page(s): e1454 - e1464
    12/02/2024 Authors: Ali ZA; Shin D; Singh M; Malik S; Sakai K; Honton B; Kereiakes DJ; Hill JM; Saito S; Mario CD
  • Natural history of a newly developed calcified nodule: incidence, predictors, and clinical outcomes.
    EuroIntervention Volume: 20 Page(s): e1330 - e1339
    11/04/2024 Authors: Sugizaki Y; Matsumura M; Chen Y; Tsukui T; Shlofmitz E; Thomas SV; Malik S; Dakroub A; Singh M; Shin D
  • Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis.
    Clin Cancer Res Volume: 30 Page(s): 4601 - 4608
    10/15/2024 Authors: Saba NF; Chaudhary R; Kirtane K; Marra A; Ekpenyong A; McCook-Veal A; Schmitt NC; Gross JH; Patel MR; Remick J
  • Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression.
    Cells Volume: 13
    10/09/2024 Authors: Sabit H; Arneth B; Abdel-Ghany S; Madyan EF; Ghaleb AH; Selvaraj P; Shin DM; Bommireddy R; Elhashash A
  • Chemoprevention of Head and Neck Cancer: A Review of Current Approaches and Future Perspectives.
    Cancer Prev Res (Phila) Volume: 17 Page(s): 443 - 455
    10/01/2024 Authors: Han S; Bommireddy R; Kim P; Selvaraj P; Shin DM
  • Assessing survival outcomes of patients with oral tongue squamous cell carcinoma: Focus on age, sex, and stage.
    Head Neck Volume: 46 Page(s): 2167 - 2177
    09/01/2024 Authors: Pamulapati S; Abousaud M; Li Y; Ekpenyong A; Rudra S; Remick JS; Bates JE; Stokes WA; McDonald MW; Schmitt NC
  • Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
    Nat Med Volume: 30 Page(s): 2373
    08/01/2024 Authors: Saba NF; Steuer CE; Ekpenyong A; McCook-Veal A; Magliocca K; Patel M; Schmitt NC; Stokes W; Bates JE; Rudra S
  • Intravascular imaging-guided percutaneous coronary intervention for heavily calcified coronary lesions: a systematic review and meta-analysis.
    Int J Cardiovasc Imaging Volume: 40 Page(s): 1653 - 1659
    08/01/2024 Authors: Shin D; Hong D; Singh M; Lee SH; Sakai K; Dakroub A; Malik S; Maehara A; Shlofmitz E; Stone GW
  • OCT-Guided vs Angiography-Guided Coronary Stent Implantation inComplexLesions: AnILUMIEN IV Substudy.
    J Am Coll Cardiol Volume: 84 Page(s): 368 - 378
    07/23/2024 Authors: Ali ZA; Landmesser U; Maehara A; Shin D; Sakai K; Matsumura M; Shlofmitz RA; Leistner D; Canova P; Alfonso F
  • Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial.
    JAMA Oncol Volume: 10 Page(s): 896 - 904
    07/01/2024 Authors: Saba NF; Wong SJ; Nasti T; McCook-Veal AA; McDonald MW; Stokes WA; Anderson AM; Ekpenyong A; Rupji M; Abousaud M
  • Distinct Challenges of Eruptive and Non-Eruptive Calcified Nodules in Percutaneous Coronary Intervention.
    Curr Cardiol Rep Volume: 26 Page(s): 757 - 765
    07/01/2024 Authors: Galougahi KK; Shin D; Dakroub A; Sakai K; Singh M; Malik S; Maehara A; Matsumura M; Mintz G; Spratt JC
  • Coronary Neointimal Healing After Intravascular Lithotripsy Compared With Orbital Atherectomy Assessed by Serial Optical Coherence Tomography.
    J Soc Cardiovasc Angiogr Interv Volume: 3 Page(s): 101977
    06/01/2024 Authors: Tsioulias A; Shin D; Singh M; Thomas SV; Sakai K; Maehara A; Khalique O; Shlofmitz ES; Moses JW; Jeremias A
  • Calcified Nodule in Percutaneous Coronary Intervention: Therapeutic Challenges.
    JACC Cardiovasc Interv Volume: 17 Page(s): 1187 - 1199
    05/27/2024 Authors: Shin D; Karimi Galougahi K; Spratt JC; Maehara A; Collet C; Barbato E; Ribichini FL; Gonzalo N; Sakai K; Mintz GS
  • We now have enough evidence to support systematic OCT in daily PCI practice: pros and cons.
    EuroIntervention Volume: 20 Page(s): 533 - 535
    05/10/2024 Authors: Ali ZA; Shin D; Chaturvedi A; Waksman R
  • Prevalence and anatomical factors associated with stent under-expansion in non-severely calcified lesions.
    Catheter Cardiovasc Interv Volume: 103 Page(s): 833 - 842
    05/01/2024 Authors: Sato T; Matsumura M; Yamamoto K; Shlofmitz E; Moses JW; Khalique OK; Shin D; Dakroub A; Singh M; Malik S
  • Editorial: Between too much and too little metal in the left main bifurcation.
    Cardiovasc Revasc Med Volume: 61 Page(s): 6 - 7
    04/01/2024 Authors: Shin D; Shlofmitz E
  • Prognostic Implications of MicrovascularResistance Reserve in Symptomatic Patients With IntermediateCoronaryStenosis.
    JACC Cardiovasc Interv Volume: 17 Page(s): 786 - 797
    03/25/2024 Authors: Lee SH; Choi KH; Hong D; Shin D; Joh HS; Kim HK; Park TK; Yang JH; Song YB; Hahn J-Y
  • Between a Rock and a Hard Place: A Consensus Statement on the Management of Calcified Coronary Lesions.
    J Soc Cardiovasc Angiogr Interv Volume: 3 Page(s): 101265
    02/01/2024 Authors: Ali ZA; Shin D; Barbato E
  • Physiologic Assessment After Percutaneous Coronary Interventions and Functionally Optimized Revascularization.
    Cardiol Clin Volume: 42 Page(s): 55 - 76
    02/01/2024 Authors: Shin D; Lee SH; Hong D; Choi KH; Lee JM
  • Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement.
    Laryngoscope Volume: 134 Page(s): 577 - 581
    02/01/2024 Authors: So RJ; Hidalgo Lopez JC; Ballestas SA; Klein AM; Steuer C; Shin DM; Abousaud M; Teng Y; Saba NF; Tkaczuk AT
  • Quantitative InVitro Investigation of Polymer Damage on Drug-Eluting Stents Resulting From Intravascular Lithotripsy.
    JACC Cardiovasc Interv Volume: 17 Page(s): 320 - 322
    01/22/2024 Authors: Beatty B; Shin D; Wolff E; Shearer M; Saggio G; Shlofmitz E; Jeremias A; Moses JW; Shlofmitz RA; Ali ZA
  • Intravascular Imaging-Guided Percutaneous Coronary Intervention Before and After Standardized Optimization Protocols.
    JACC Cardiovasc Interv Volume: 17 Page(s): 292 - 303
    01/22/2024 Authors: Kwon W; Hong D; Choi KH; Lee SH; Shin D; Lee J-Y; Lee S-J; Lee SY; Kim SM; Yun KH
  • Cost-Effectiveness of Fractional Flow Reserve-Guided Treatment for Acute Myocardial Infarction and Multivessel Disease: A Prespecified Analysis of the FRAME-AMI Randomized Clinical Trial.
    JAMA Netw Open Volume: 7 Page(s): e2352427
    01/02/2024 Authors: Hong D; Lee SH; Lee J; Lee H; Shin D; Kim HK; Park KH; Choo EH; Kim CJ; Kim MC
  • Correction: Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC).
    PLoS One Volume: 19 Page(s): e0308819
    01/01/2024 Authors: Saba NF; Dinasarapu AR; Magliocca KR; Dwivedi B; Seby S; Qin ZS; Patel M; Griffith CC; Wang X; El-Deiry M
  • Associations of differentially expressed genes with psychoneurological symptoms in patients with head and neck cancer: A longitudinal study.
    J Psychosom Res Volume: 175 Page(s): 111518
    12/01/2023 Authors: Lin Y; Peng G; Bruner DW; Miller AH; Saba NF; Higgins KA; Shin DM; Claussen H; Johnston HR; Houser MC
  • Intravascular imaging: a glass half empty or half full?
    Eur Heart J Volume: 44 Page(s): 3856 - 3858
    10/12/2023 Authors: Ali ZA; Shin D
  • QFR Assessment and Prognosis AfterNonculprit PCI in Patients With Acute Myocardial Infarction.
    JACC Cardiovasc Interv Volume: 16 Page(s): 2365 - 2379
    10/09/2023 Authors: Lee SH; Hong D; Shin D; Kim HK; Park KH; Choo EH; Kim CJ; Kim MC; Hong YJ; Ahn SG
  • Effect of Supersaturated Oxygen Therapy on Coronary Microcirculatory Function in Patients With Anterior STEMI.
    JACC Cardiovasc Interv Volume: 16 Page(s): 2469 - 2471
    10/09/2023 Authors: Shin D; Dai N; Wilburn P; Choi KH; Lee SH; Kim HK; Maehara A; Stone GW; Myung Lee J
  • Impact of Calcium Eccentricity on the Safety and Effectiveness of Coronary Intravascular Lithotripsy: Pooled Analysis From the Disrupt CAD Studies.
    Circ Cardiovasc Interv Volume: 16 Page(s): e012898
    10/01/2023 Authors: Ali ZA; Kereiakes DJ; Hill JM; Saito S; Di Mario C; Honton B; Gonzalo N; Riley RF; Maehara A; Matsumura M
  • Circulating short chain fatty acids and fatigue in patients with head and neck cancer: A longitudinal prospective study.
    Brain Behav Immun Volume: 113 Page(s): 432 - 443
    10/01/2023 Authors: Xiao C; Fedirko V; Claussen H; Richard Johnston H; Peng G; Paul S; Maner-Smith KM; Higgins KA; Shin DM; Saba NF
  • Long-Term Follow-up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis.
    Laryngoscope Volume: 133 Page(s): 2725 - 2733
    10/01/2023 Authors: Ballestas SA; Hidalgo Lopez J; Klein AM; Steuer C; Shin DM; Abousaud M; Schmitt NC; Teng Y; Saba NF; Tkaczuk AT
  • Differential predictability for high-risk plaque characteristics between fractional flow reserve and instantaneous wave-free ratio.
    Sci Rep Volume: 13 Page(s): 16005
    09/25/2023 Authors: Lee JM; Shin D; Lee SH; Choi KH; Kim SM; Chun EJ; Lee KY; Hwang D; Ahn SG; Brown AJ
  • Associations of inflammation with neuropsychological symptom cluster in patients with Head and neck cancer: A longitudinal study.
    Brain Behav Immun Health Volume: 30 Page(s): 100649
    07/01/2023 Authors: Amirkhanzadeh Barandouzi Z; Bruner DW; Miller AH; Paul S; Felger JC; Wommack EC; Higgins KA; Shin DM; Saba NF; Xiao C
  • Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
    Nat Med Volume: 29 Page(s): 880 - 887
    04/01/2023 Authors: Saba NF; Steuer CE; Ekpenyong A; McCook-Veal A; Magliocca K; Patel M; Schmitt NC; Stokes W; Bates JE; Rudra S
  • Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral Blood.
    Int J Radiat Oncol Biol Phys Volume: 115 Page(s): 1217 - 1228
    04/01/2023 Authors: Qian DC; Ulrich BC; Peng G; Zhao H; Conneely KN; Miller AH; Bruner DW; Eldridge RC; Wommack EC; Higgins KA
  • Prognosis after discontinuing renin angiotensin aldosterone system inhibitor for heart failure with restored ejection fraction after acute myocardial infarction.
    Sci Rep Volume: 13 Page(s): 3539
    03/02/2023 Authors: Lee SH; Rhee T-M; Shin D; Hong D; Choi KH; Kim HK; Park TK; Yang JH; Song YB; Hahn J-Y
  • Prognostic Impact of Coronary Microvascular Dysfunction According to Different Patterns by Invasive Physiologic Indexes in Symptomatic Patients With Intermediate Coronary Stenosis.
    Circ Cardiovasc Interv Volume: 16 Page(s): e012621
    03/01/2023 Authors: Hong D; Shin D; Lee SH; Joh HS; Choi KH; Kim HK; Ha SJ; Park TK; Yang JH; Song YB
  • Prognostic Impact of Indeterminate Diastolic Function in Patients With Functionally Insignificant Coronary Stenosis.
    J Am Soc Echocardiogr Volume: 36 Page(s): 295 - 306.e5
    03/01/2023 Authors: Chung YJ; Choi KH; Lee SH; Shin D; Hong D; Park S; Joh HS; Kim HK; Ha SJ; Park TK
  • Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function on Cardiovascular Death.
    J Am Heart Assoc Volume: 12 Page(s): e027690
    02/07/2023 Authors: Hong D; Lee SH; Shin D; Choi KH; Kim HK; Ha SJ; Joh HS; Park TK; Yang JH; Song YB
  • Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice.
    J Korean Med Sci Volume: 38 Page(s): e34
    02/06/2023 Authors: Lee JM; Joh HS; Choi KH; Hong D; Park TK; Yang JH; Song YB; Choi J-H; Choi S-H; Jeong J-O
  • Physiologic Assessment After Percutaneous Coronary Interventions and Functionally Optimized Revascularization.
    Interv Cardiol Clin Volume: 12 Page(s): 55 - 69
    01/01/2023 Authors: Shin D; Lee SH; Hong D; Choi KH; Lee JM
  • Functional angiography-derived index of microcirculatory resistance validated with microvascular obstruction in cardiac magnetic resonance after STEMI.
    Rev Esp Cardiol (Engl Ed) Volume: 75 Page(s): 786 - 796
    10/01/2022 Authors: Shin D; Kim J; Choi KH; Dai N; Li Y; Lee SH; Joh HS; Kim HK; Kim S-M; Ha SJ
  • A network analysis of self-reported psychoneurological symptoms in patients with head and neck cancer undergoing intensity-modulated radiotherapy.
    Cancer Volume: 128 Page(s): 3734 - 3743
    10/01/2022 Authors: Lin Y; Bruner DW; Paul S; Miller AH; Saba NF; Higgins KA; Shin DM; Zhang W; Miaskowski C; Xiao C
  • Prognostic Impact of Coronary Flow Reserve in Patients With Reduced Left Ventricular Ejection Fraction.
    J Am Heart Assoc Volume: 11 Page(s): e025841
    08/02/2022 Authors: Joh HS; Shin D; Lee JM; Lee SH; Hong D; Choi KH; Hwang D; Boerhout CKM; de Waard GA; Jung J-H
  • Oral human papillomavirus prevalence, persistence, and risk-factors in HIV-positive and HIV-negative adults.
    Tumour Virus Res Volume: 13 Page(s): 200237
    06/01/2022 Authors: Riddell J; Brouwer AF; Walline HM; Campredon LP; Meza R; Eisenberg MC; Andrus EC; Delinger RL; Yost ML; McCloskey JK
  • Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.
    Clin Cancer Res Volume: 28 Page(s): 2329 - 2338
    06/01/2022 Authors: Chung CH; Li J; Steuer CE; Bhateja P; Johnson M; Masannat J; Poole MI; Song F; Hernandez-Prera JC; Molina H
  • A Multicenter Randomized Phase II Study of Single Agent Efficacy and Optimal Combination Sequence of Everolimus and Pasireotide LAR in Advanced Thyroid Cancer.
    Cancers (Basel) Volume: 14
    05/26/2022 Authors: Bauman JE; Chen Z; Zhang C; Ohr JP; Ferris RL; McGorisk GM; Brandt S; Srivatsa S; Chen AY; Steuer CE
  • Differential Prognostic Value of Revascularization for Coronary Stenosis With Intermediate FFR by Coronary FlowReserve.
    JACC Cardiovasc Interv Volume: 15 Page(s): 1033 - 1043
    05/23/2022 Authors: Kim J; Shin D; Lee JM; Lee SH; Hong D; Choi KH; Hwang D; Boerhout CKM; de Waard GA; Jung J-H
  • Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction.
    J Am Heart Assoc Volume: 11 Page(s): e025171
    05/03/2022 Authors: Lee SH; Shin D; Lee JM; van de Hoef TP; Hong D; Choi KH; Hwang D; Boerhout CKM; de Waard GA; Jung J-H
  • Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Is FFR-Guided Strategy Still Valuable?
    Korean Circ J Volume: 52 Page(s): 280 - 287
    04/01/2022 Authors: Shin D; Rhee T-M; Lee SH; Lee JM
  • Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas.
    Oncologist Volume: 27 Page(s): 48 - 56
    02/03/2022 Authors: Vijayvargiya P; Trivedi S; Rupji M; Song H; Liu Y; Jiang R; Kaka AS; Chen GZ; Stokes W; Steuer C
  • The omission of intentional primary site radiation following transoral robotic surgery in 59 patients: No local-regional failures.
    Head Neck Volume: 44 Page(s): 382 - 390
    02/01/2022 Authors: Dhere VR; Escott CE; Tian S; Switchenko JM; Bell JP; Stokes WA; McDonald MW; Magliocca KR; Boyce BJ; Kaka AS
  • Cytomorphologic and immunophenotypical analysis of SMARCA4 (BRG1)-deficient non-small cell lung carcinoma.
    J Am Soc Cytopathol Volume: 11 Page(s): 183 - 193
    01/01/2022 Authors: Ogunbona OB; Lin X; Hornick JL; Lubin DJ; Wang Q; Reid MD; Schneider F; Li D; Shin DM; Shi Q
  • CA209-9KY: Phase II Study of IMRT Re-Irradiation and Concurrent/Adjuvant Nivolumab (Nivo) in Patients With Loco Regionally Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma (HNSCC) - Toxicity and Quality of Life (QoL) Results
    Volume: 111 Page(s): E361 - E361
    11/01/2021 Authors: Saba NF; Wong S; Stokes WA; Rupji M; Liu Y; Rudra S; Bates JE; Steuer C; Remick JS; Cummings K
  • Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-Treatment DNA Methylation in Peripheral Blood.
    Int J Radiat Oncol Biol Phys Volume: 111 Page(s): S143 - S144
    11/01/2021 Authors: Qian DC; Ulrich BC; Peng G; Zhao H; Conneely KN; Miller AH; Bruner DW; Eldridge RC; Wommack EC; Higgins KA
  • CA209-9KY: Phase II Study of IMRT Re-Irradiation and Concurrent/Adjuvant Nivolumab (Nivo) in Patients With Loco Regionally Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma (HNSCC) - Toxicity and Quality of Life (QoL) Results.
    Int J Radiat Oncol Biol Phys Volume: 111 Page(s): e361
    11/01/2021 Authors: Saba NF; Wong S; Stokes WA; Rupji M; Liu Y; Rudra S; Bates JE; Steuer C; Remick JS; Cummings K
  • Tipifarnib enhances anti-EGFR activity of cetuximab in non-HRas mutated head and neck squamous cell carcinoma cancer (HNSCC).
    Oral Oncol Volume: 122 Page(s): 105546
    11/01/2021 Authors: Shu L; Wang D; Nannapaneni S; Sun Y; Griffith CC; Wang X; Chen Z; Patel M; El-Deiry M; Shin DM
  • Plasma Metabolic Phenotypes of HPV-Associated versus Smoking-Associated Head and Neck Cancer and Patient Survival.
    Cancer Epidemiol Biomarkers Prev Volume: 30 Page(s): 1858 - 1866
    10/01/2021 Authors: Eldridge RC; Uppal K; Hayes DN; Smith MR; Hu X; Qin ZS; Beitler JJ; Miller AH; Wommack EC; Higgins KA
  • Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study.
    Cancer Volume: 127 Page(s): 3361 - 3371
    09/15/2021 Authors: Xiao C; Beitler JJ; Peng G; Levine ME; Conneely KN; Zhao H; Felger JC; Wommack EC; Chico CE; Jeon S
  • Incidence trends of squamous cell carcinoma of the head and neck (SCCHN) in the aging population--A SEER-based analysis from 2000 to 2016.
    Cancer Med Volume: 10 Page(s): 6070 - 6077
    09/01/2021 Authors: Taylor MA; Switchenko J; Stokes W; Patel MR; McDonald M; Steuer C; Aiken A; Beitler JJ; Shin DM; Saba NF
  • Association of Epigenetic Age Acceleration With Risk Factors, Survival, and Quality of Life in Patients With Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys Volume: 111 Page(s): 157 - 167
    09/01/2021 Authors: Xiao C; Miller AH; Peng G; Levine ME; Conneely KN; Zhao H; Eldridge RC; Wommack EC; Jeon S; Higgins KA
  • Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer.
    Nature Volume: 597 Page(s): 279 - 284
    09/01/2021 Authors: Eberhardt CS; Kissick HT; Patel MR; Cardenas MA; Prokhnevska N; Obeng RC; Nasti TH; Griffith CC; Im SJ; Wang X
  • Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1.
    Nat Commun Volume: 12 Page(s): 4960
    08/16/2021 Authors: Pan C; Kang J; Hwang JS; Li J; Boese AC; Wang X; Yang L; Boggon TJ; Chen GZ; Saba NF
  • The role of the gut microbiome in cancer-related fatigue: pilot study on epigenetic mechanisms.
    Support Care Cancer Volume: 29 Page(s): 3173 - 3182
    06/01/2021 Authors: Xiao C; Fedirko V; Beitler J; Bai J; Peng G; Zhou C; Gu J; Zhao H; Lin I-H; Chico CE
  • Physiology-Based Revascularization: A New Approach to Plan and Optimize Percutaneous CoronaryIntervention.
    JACC Asia Volume: 1 Page(s): 14 - 36
    06/01/2021 Authors: Lee JM; Lee SH; Shin D; Choi KH; van de Hoef TP; Kim HK; Samady H; Kakuta T; Matsuo H; Koo B-K
  • Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth invivo in head and neck cancer models.
    Oncol Rep Volume: 45
    05/01/2021 Authors: Amin ARMR; Wang D; Nannapaneni S; Lamichhane R; Chen ZG; Shin DM
  • Socioeconomic Factors Influence the Impact of Tumor HPV Status on Outcome of Patients With Oropharyngeal Squamous Cell Carcinoma.
    JCO Oncol Pract Volume: 17 Page(s): e313 - e322
    03/01/2021 Authors: Marks JA; Switchenko JM; Steuer CE; Ryan M; Patel MR; McDonald MW; Higgins K; Beitler JJ; Shin DM; Gillespie TW
  • Parenteral Bevacizumab for the Treatment of Severe Respiratory Papillomatosis in an Adult Population.
    Laryngoscope Volume: 131 Page(s): E921 - E928
    03/01/2021 Authors: Tkaczuk A; Trivedi S; Mody MD; Steuer CE; Shin DM; Klein AM; Saba NF
  • Corrigendum to "FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway" [Canc. Lett. 363 (2015) 166-175].
    Cancer Lett Volume: 498 Page(s): 249 - 250
    02/01/2021 Authors: Haque A; Rahman MA; Fuchs JR; Chen Z; Khuri FR; Shin DM; Amin ARMR
  • Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma.
    PLoS One Volume: 16 Page(s): e0247498
    01/01/2021 Authors: Nannapaneni S; Griffith CC; Magliocca KR; Chen W; Lyu X; Chen Z; Wang D; Wang X; Shin DM; Chen ZG
  • Combinatorial approaches targeting the EGFR family and c-Met in SCCHN.
    Oral Oncol Volume: 112 Page(s): 105074
    01/01/2021 Authors: Wang D; Lu Y; Nannapaneni S; Griffith CC; Steuer C; Qian G; Wang X; Chen Z; Patel M; El-Deiry M
  • Metabolic differences between human papillomavirus-related and smoking-related squamous cell carcinoma of the head and neck independently predict overall patient survival.
    Volume: 80
    12/01/2020 Authors: Eldridge RC; Uppal K; Beitler J; Higgins K; Wommack EC; Shin DM; Saba NF; Miller A; Bruner DW; Xiao C
  • Outcomes and Predictive Value of Post-adjuvant Therapy PET/CT for Locally Advanced Oral Squamous Cell Carcinoma.
    Laryngoscope Volume: 130 Page(s): E850 - E857
    12/01/2020 Authors: Qian DC; Magliocca KR; Aiken AH; Baugnon KL; Brandon DC; Stokes WA; McDonald MW; Patel MR; Baddour HM; Kaka AS
  • Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and Neck.
    Clin Cancer Res Volume: 26 Page(s): 5860 - 5868
    11/15/2020 Authors: Shin DM; Nannapaneni S; Patel MR; Shi Q; Liu Y; Chen Z; Chen AY; El-Deiry MW; Beitler JJ; Steuer CE
  • EARLY SAFETY AND EFFICACY OF A PHASE 1/2 OPEN-LABEL, MULTI-CENTER TRIAL OF SNS-301 ADDED TO PEMBROLIZUMAB IN PATIENTS WITH ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
    Volume: 8 Page(s): A213 - A214
    11/01/2020 Authors: Algazi A; Smith W; Panella T; Shin D; Fjaellskog M-L; Celebi J; Drumheller A; Campbell J; Pierce R; Guarino M
  • Impact of Postoperative Radiation Therapy Timing on Survival in HPV-Associated Oropharyngeal Squamous Cell Carcinoma
    Volume: 108 Page(s): E805 - E805
    11/01/2020 Authors: Tian S; Switchenko J; Patel MR; Saba NF; Shin DM; Steuer C; Dhere VR; McDonald MW; Higgins KA; Beitler JJ
  • Editor's Note: The Pivotal Role of Integrin 1 in Metastasis of Head and Neck Squamous Cell Carcinoma.
    Clin Cancer Res Volume: 26 Page(s): 5052
    09/15/2020 Authors: Wang D; Mller S; Ruhul Amin ARM; Huang D; Su L; Hu Z; Rahman MA; Nannapaneni S; Koenig L; Chen Z
  • Gut Microbiome Associated with the Psychoneurological Symptom Cluster in Patients with Head and Neck Cancers.
    Cancers (Basel) Volume: 12
    09/06/2020 Authors: Bai J; Bruner DW; Fedirko V; Beitler JJ; Zhou C; Gu J; Zhao H; Lin I-H; Chico CE; Higgins KA
  • Effects of cetuximab and CD-3379 on cytokine/chemokine balance in the tumor micro-environment (TME) of squamous cell carcinoma of the head and neck (SCCHN)
    Volume: 80
    08/01/2020 Authors: Wang D; Nannapaneni S; Lesinski GB; Shin DM; Saba NF; Chen GZ
  • Src-Met signaling confers apoptosis resistance to EGFR and PI3K co-targeting independently of AKT and ERK pathway activation in head and neck cancer
    Volume: 80
    08/01/2020 Authors: Anisuzzaman AS; Haque A; Chen ZG; Shin DM; Amin ARMR
  • Corrigendum: Systemic Delivery of Bc12-Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth.
    Angew Chem Int Ed Engl Volume: 59 Page(s): 12575
    07/27/2020 Authors: Rahman MA; Wang P; Zhao Z; Wang D; Nannapaneni S; Zhang C; Chen Z; Griffith CC; Hurwitz SJ; Chen ZG
  • COMPARISON OF THE 7TH AND 8TH EDITIONS OF THE AMERICAN JOINT COMMITTEE ON CANCER (AJCC) STAGING FOR OROPHARYNGEAL SQUAMOUS CELL CARCINOMAS (OPSCC): A SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS PROGRAM (SEER) DATABASE ANALYSIS
    Volume: 35 Page(s): S72 - S72
    07/01/2020 Authors: Vijayvargiya P; Trivedi S; Song H; Liu Y; Steuer C; Stokes W; Kaka A; Patel M; Chen G; Shin D
  • Trimodality Therapy in the Treatment of Stage III N2-Positive Non-Small Cell Lung Cancer: A National Cancer Database Analysis.
    Oncologist Volume: 25 Page(s): e964 - e975
    06/01/2020 Authors: Behera M; Steuer CE; Liu Y; Fernandez F; Fu C; Higgins KA; Gillespie TW; Pakkala S; Pillai RN; Force S
  • Association Among Glucocorticoid Receptor Sensitivity, Fatigue, and Inflammation in Patients With Head and Neck Cancer.
    Psychosom Med Volume: 82 Page(s): 508 - 516
    06/01/2020 Authors: Xiao C; Eldridge RC; Beitler JJ; Higgins KA; Chico CE; Felger JC; Wommack EC; Knobf T; Saba NF; Shin DM
  • Demographic and Socioeconomic Factors Associated With Metastases at Presentation in HPV-Related Squamous Cell Carcinoma of the Head and Neck: An NCDB Analysis.
    JCO Oncol Pract Volume: 16 Page(s): e476 - e487
    06/01/2020 Authors: Bean MB; Switchenko JM; Steuer CE; Patel M; Higgins K; McDonald M; Chen GZ; Beitler JJ; Shin DM; Gillespie T
  • Tumor membrane vesicle-based vaccine immunotherapy inhibits tumor growth and metastasis of squamous cell carcinoma of head and neck in mice
    Volume: 204
    05/01/2020 Authors: Bommireddy R; Munoz LE; Pack C; Ramachandiran S; Reddy S; Chen G; Saba N; Shin DM; Selvaraj P
  • Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer.
    Vaccines (Basel) Volume: 8
    04/14/2020 Authors: Bommireddy R; Munoz LE; Kumari A; Huang L; Fan Y; Monterroza L; Pack CD; Ramachandiran S; Reddy SJC; Kim J
  • Outcomes and Predictive Value of Post-Adjuvant Therapy Surveillance PET/CECT for Locally Advanced Oral Squamous Cell Carcinoma
    Volume: 106 Page(s): 1180 - 1180
    04/01/2020 Authors: Qian DC; Magliocca KR; Aiken AH; Baugnon KL; Brandon DC; Stokes WA; McDonald MW; Patel MR; Baddour HM; Kaka AS
  • Comparison of the 7th and 8th editions of the American Joint Committee on Cancer (AJCC) staging for oropharyngeal squamous cell carcinomas (OPSCC): A Surveillance, Epidemiology and End Results Program (SEER) database analysis
    Volume: 106 Page(s): 1200 - 1201
    04/01/2020 Authors: Vijayvargiya P; Trivedi S; Song H; Liu Y; Steuer C; Stokes WA; Kaka AS; Patel MR; Chen G; Shin DM
  • Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC).
    PLoS One Volume: 15 Page(s): e0238497
    01/01/2020 Authors: Saba NF; Dinasarapu AR; Magliocca KR; Dwivedi B; Seby S; Qin ZS; Patel M; Griffith CC; Wang X; El-Deiry M
  • Small Cell and Squamous Cell Carcinomas of the Head and Neck: Comparing Incidence and Survival Trends Based on Surveillance, Epidemiology, and End Results (SEER) Data.
    Oncologist Volume: 24 Page(s): 1562 - 1569
    12/01/2019 Authors: Bean MB; Liu Y; Jiang R; Steuer CE; Patel M; McDonald MW; Higgins KA; Beitler JJ; Shin DM; Saba NF
  • Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation.
    J Clin Invest Volume: 129 Page(s): 4110 - 4123
    10/01/2019 Authors: Pan C; Chun J; Li D; Boese AC; Li J; Kang J; Umano A; Jiang Y; Song L; Magliocca KR
  • Tumor membrane vesicle-based vaccine inhibits growth of squamous cell carcinoma of head and neck in mice
    Volume: 49 Page(s): 1693 - 1693
    10/01/2019 Authors: Bommireddy R; Munoz L; Pack C; Ramachandiran S; Reddy S; Kim J; Chen G; Saba N; Shin D; Selvaraj P
  • Systemic bevacizumab for the treatment of recurrent respiratory papillomatosis: A retrospective analysis from an academic tertiary care center
    Volume: 30
    10/01/2019 Authors: Trivedi S; Steuer CE; Tkaczuk AT; Shin DM; Klein A; Saba NF
  • Interleukin-6/STAT3 Signaling is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell Carcinoma.
    Head Neck Pathol Volume: 13 Page(s): 304 - 312
    09/01/2019 Authors: Lesinski GB; Nannapaneni S; Griffith CC; Patel M; Chen W; Chen Z; Ahmed R; Wieland A; Shin DM; Chen ZG
  • The Immune Landscape of Cancer.
    Immunity Volume: 51 Page(s): 411 - 412
    08/20/2019 Authors: Thorsson V; Gibbs DL; Brown SD; Wolf D; Bortone DS; Ou Yang T-H; Porta-Pardo E; Gao GF; Plaisier CL; Eddy JA
  • RNA-based nanostructures for therapeutic siRNA delivery
    Volume: 79
    07/01/2019 Authors: Ke Y; Shin D; Chen G
  • TMV vaccine inhibits growth of squamous cell carcinoma of head and neck in mice
    Volume: 79
    07/01/2019 Authors: Bommireddy R; Munoz L; Pack CD; Ramachandiran S; Reddy SJC; Kim J; Chen G; Saba NF; Shin DM; Selvaraj P
  • Effective treatment of squamous cell carcinoma of the head and neck (HNSCC) using a combined regimen of tipifarnib and cetuximab
    Volume: 79
    07/01/2019 Authors: Shu L; Wang D; Nannapaneni S; Shin DM; Saba NF; Chen GZ
  • Comparison of the seventh and eighth editions of the American Joint Committee on Cancer (AJCC) staging for oropharyngeal squamous cell carcinomas (OPSCC): A Surveillance, Epidemiology and End Results Program (SEER) database analysis.
    Volume: 37
    05/20/2019 Authors: Trivedi S; Song H; Liu Y; Steuer CE; Stokes W; Kaka A; Patel M; Chen ZG; Shin DM; Aiken A
  • Socioeconomic contributions to clinical outcome by HPV status in squamous cell carcinomas of the head and neck (SCCHN):An analysis of NCDB.
    Volume: 37
    05/20/2019 Authors: Marks JA; Switchenko JM; Steuer CE; Herrin S; Ryan MA; Patel M; El-Deiry M; Beitler JJ; Shin DM; Gillespie TW
  • Phase 1b study of chemoprevention with green tea polyphenon E (PPE) and epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (Erlotinib) in patients (pts) with advanced premalignant (AP) lesions of the head and neck.
    Volume: 37
    05/20/2019 Authors: Shin DM; Beitler JJ; El-Deiry M; Steuer CE; Chen AY; Baddour HM; Chen ZG; Roser S; Magliocca KR; Patel M
  • Factors associated with metastatic presentation in HPV-related squamous cell carcinoma of the head and neck (SCCHN): A National Cancer Database (NCDB) analysis.
    Volume: 37
    05/20/2019 Authors: Bean MB; Switchenko JM; Steuer CE; Patel M; El-Deiry M; Higgins KA; McDonald MW; Chen ZG; Beitler JJ; Shin DM
  • A randomized phase II study of tremelimumab and durvalumab with or without radiation for patients with relapsed small cell lung cancer (SCLC).
    Volume: 37
    05/20/2019 Authors: Owonikoko TK; Higgins KA; Chen Z; Zhang C; Pillai RN; Steuer CE; Saba NF; Pakkala S; Shin DM; Zhang G
  • Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance.
    J Clin Invest Volume: 129 Page(s): 2431 - 2445
    05/13/2019 Authors: Pan C; Jin L; Wang X; Li Y; Chun J; Boese AC; Li D; Kang H-B; Zhang G; Zhou L
  • Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis.
    Volume: 41 Page(s): 1490 - 1498
    05/01/2019 Authors: Mohamed A; Twardy B; Zordok MA; Ashraf K; Alkhoder A; Schrapp K; Steuer C; Chen Z; Pakkala S; Pillai R
  • Phase IB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy, Carboplatin, and Everolimus in Patients With Locally Advanced Esophageal Cancer.
    Am J Clin Oncol Volume: 42 Page(s): 331 - 336
    04/01/2019 Authors: Saba NF; Force S; Staley C; Fernandez F; Willingham F; Pickens A; Cardona K; Chen Z; Goff L; Cardin D
  • Measurement of circulating tumor cells in squamous cell carcinoma of the head and neck and patient outcomes.
    Clin Transl Oncol Volume: 21 Page(s): 342 - 347
    03/01/2019 Authors: Morgan TM; Wang X; Qian X; Switchenko JM; Nie S; Patel KR; Cassidy RJ; Shin DM; Beitler JJ
  • Smoking, age, nodal disease, T stage, p16 status, and risk of distant metastases in patients with squamous cell cancer of the oropharynx.
    Cancer Volume: 125 Page(s): 704 - 711
    03/01/2019 Authors: Beitler JJ; Switchenko JM; Dignam JJ; McDonald MW; Saba NF; Shin DM; Magliocca KR; Cassidy RJ; El-Deiry MW; Patel MR
  • A continuous-flow acoustofluidic cytometer for single-cell mechanotyping.
    Lab Chip Volume: 19 Page(s): 387 - 393
    01/29/2019 Authors: Wang H; Liu Z; Shin DM; Chen ZG; Cho Y; Kim Y-J; Han A
  • Prognostic implications of peritumoral vasculature in head and neck cancer.
    Cancer Med Volume: 8 Page(s): 147 - 154
    01/01/2019 Authors: Evans M; Baddour HM; Magliocca KR; Mller S; Nannapaneni S; Chen AY; Kim S; Chen Z; Shin DM; Wang AY
  • Soy Isoflavone Supplementation Increases Long Interspersed Nucleotide Element-1 (LINE-1) Methylation in Head and Neck Squamous Cell Carcinoma.
    Nutr Cancer Volume: 71 Page(s): 772 - 780
    01/01/2019 Authors: Rozek LS; Virani S; Bellile EL; Taylor JMG; Sartor MA; Zarins KR; Virani A; Cote C; Worden FP; Mark MEP
  • Differential regulation of NF-kB and IRF target genes as they relate to fatigue in patients with head and neck cancer.
    Brain Behav Immun Volume: 74 Page(s): 291 - 295
    11/01/2018 Authors: Xiao C; Beitler JJ; Higgins KA; Wommack EC; Saba NF; Shin DM; Bruner DW; Miller AH; Cole S
  • Pilot Study of Potential Activation of c-MYC by Aurora Kinase A in Everolimus-Resistant Localized Esophageal Cancer Treated with XELOX followed by Carboplatin/Radiation
    Volume: 102 Page(s): E27 - E27
    11/01/2018 Authors: Saba NF; Force S; Staley CA; Fernandez F; Willingham FF; Pickens A; Cardona K; Chen Z; Goff L; Cardin D
  • Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer.
    Cell Rep Volume: 25 Page(s): 1304 - 1317.e5
    10/30/2018 Authors: Wang Y; Xu X; Maglic D; Dill MT; Mojumdar K; Ng PK-S; Jeong KJ; Tsang YH; Moreno D; Bhavana VH
  • A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF- Superfamily.
    Cell Syst Volume: 7 Page(s): 422 - 437.e7
    10/24/2018 Authors: Korkut A; Zaidi S; Kanchi RS; Rao S; Gough NR; Schultz A; Li X; Lorenzi PL; Berger AC; Robertson G
  • Latent class analysis of fatigue in patients with head and neck cancer
    Volume: 27 Page(s): S63 - S63
    10/01/2018 Authors: Xiao C; Eldridge R; Higgins K; Saba N; Shin D; Miller A; Bruner D; Beitler J
  • Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.
    Cancer Cell Volume: 34 Page(s): 211 - 224.e6
    08/13/2018 Authors: Kahles A; Lehmann K-V; Toussaint NC; Hser M; Stark SG; Sachsenberg T; Stegle O; Kohlbacher O; Sander C; Cancer Genome Atlas Research Network
  • MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation.
    Cancer Cell Volume: 34 Page(s): 315 - 330.e7
    08/13/2018 Authors: Jin L; Chun J; Pan C; Li D; Lin R; Alesi GN; Wang X; Kang H-B; Song L; Wang D
  • Comprehensive Characterization of Cancer Driver Genes and Mutations.
    Cell Volume: 174 Page(s): 1034 - 1035
    08/09/2018 Authors: Bailey MH; Tokheim C; Porta-Pardo E; Sengupta S; Bertrand D; Weerasinghe A; Colaprico A; Wendl MC; Kim J; Reardon B
  • Associations among human papillomavirus, inflammation, and fatigue in patients with head and neck cancer.
    Cancer Volume: 124 Page(s): 3163 - 3170
    08/01/2018 Authors: Xiao C; Beitler JJ; Higgins KA; Glazer T; Huynh LK; Paul S; Felger JC; Wommack EC; Saba NF; Shin DM
  • Effective reduction of PD-L1 expression by simultaneous blockade of EGFR and HER3 (ErbB3) in head and neck cancer
    Volume: 78
    07/01/2018 Authors: Chen ZG; Wang D; Griffith CC; Nannapaneni S; Steuer C; Patel MR; El-Deiry MW; Wang X; Zhang Y; Chen Z
  • Predicting fatigue levels of head and neck cancer patients with gene expression using machine learning
    Volume: 78
    07/01/2018 Authors: Eldridge RC; Miller AH; Bruner DW; Beitler JJ; Higgins KA; Wommack EC; Linh KH; Saba NF; Shin DM; Xiao C
  • Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinoma.
    Oral Oncol Volume: 82 Page(s): 83 - 90
    07/01/2018 Authors: Ferrarotto R; William WN; Tseng JE; Marur S; Shin DM; Murphy B; Cohen EEW; Thomas CY; Willey R; Cosaert J
  • The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
    Cell Rep Volume: 23 Page(s): 3698
    06/19/2018 Authors: Ricketts CJ; De Cubas AA; Fan H; Smith CC; Lang M; Reznik E; Bowlby R; Gibb EA; Akbani R; Beroukhim R
  • Racial disparities in surgical management and survival in hispanic patients with potentially resectable esophageal cancer.
    Volume: 36
    05/20/2018 Authors: Gupta D; Liu Y; Jiang R; Fernandez F; Force S; Pickens A; Steuer CE; McDonald MW; Higgins KA; Beitler JJ
  • ICR gene signature to identify differential immune landscapes in anatomic subsites of head and neck squamous cell carcinomas and implications in personalized medicine.
    Volume: 36
    05/20/2018 Authors: Pai SI; Clayburgh D; Patel M; Bell RB; Yueh B; Lin D; Halliwell K; Turan T; Samayoa J; Cairns B
  • The Immune Landscape of Cancer.
    Immunity Volume: 48 Page(s): 812 - 830.e14
    04/17/2018 Authors: Thorsson V; Gibbs DL; Brown SD; Wolf D; Bortone DS; Ou Yang T-H; Porta-Pardo E; Gao GF; Plaisier CL; Eddy JA
  • A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
    Cancer Cell Volume: 33 Page(s): 690 - 705.e9
    04/09/2018 Authors: Berger AC; Korkut A; Kanchi RS; Hegde AM; Lenoir W; Liu W; Liu Y; Fan H; Shen H; Ravikumar V
  • Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.
    Cancer Cell Volume: 33 Page(s): 721 - 735.e8
    04/09/2018 Authors: Liu Y; Sethi NS; Hinoue T; Schneider BG; Cherniack AD; Sanchez-Vega F; Seoane JA; Farshidfar F; Bowlby R; Islam M
  • lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer.
    Cancer Cell Volume: 33 Page(s): 706 - 720.e9
    04/09/2018 Authors: Wang Z; Yang B; Zhang M; Guo W; Wu Z; Wang Y; Jia L; Li S; Cancer Genome Atlas Research Network; Xie W
  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy.
    Cancer Cell Volume: 33 Page(s): 676 - 689.e3
    04/09/2018 Authors: Taylor AM; Shih J; Ha G; Gao GF; Zhang X; Berger AC; Schumacher SE; Wang C; Hu H; Liu J
  • Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
    Cell Volume: 173 Page(s): 305 - 320.e10
    04/05/2018 Authors: Ding L; Bailey MH; Porta-Pardo E; Thorsson V; Colaprico A; Bertrand D; Gibbs DL; Weerasinghe A; Huang K-L; Tokheim C
  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
    Cell Volume: 173 Page(s): 291 - 304.e6
    04/05/2018 Authors: Hoadley KA; Yau C; Hinoue T; Wolf DM; Lazar AJ; Drill E; Shen R; Taylor AM; Cherniack AD; Thorsson V
  • Pathogenic Germline Variants in 10,389 Adult Cancers.
    Cell Volume: 173 Page(s): 355 - 370.e14
    04/05/2018 Authors: Huang K-L; Mashl RJ; Wu Y; Ritter DI; Wang J; Oh C; Paczkowska M; Reynolds S; Wyczalkowski MA; Oak N
  • A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples.
    Cell Volume: 173 Page(s): 386 - 399.e12
    04/05/2018 Authors: Chen H; Li C; Peng X; Zhou Z; Weinstein JN; Cancer Genome Atlas Research Network; Liang H
  • Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.
    Cell Volume: 173 Page(s): 338 - 354.e15
    04/05/2018 Authors: Malta TM; Sokolov A; Gentles AJ; Burzykowski T; Poisson L; Weinstein JN; Kamiska B; Huelsken J; Omberg L; Gevaert O
  • Oncogenic Signaling Pathways in The Cancer Genome Atlas.
    Cell Volume: 173 Page(s): 321 - 337.e10
    04/05/2018 Authors: Sanchez-Vega F; Mina M; Armenia J; Chatila WK; Luna A; La KC; Dimitriadoy S; Liu DL; Kantheti HS; Saghafinia S
  • An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.
    Cell Volume: 173 Page(s): 400 - 416.e11
    04/05/2018 Authors: Liu J; Lichtenberg T; Hoadley KA; Poisson LM; Lazar AJ; Cherniack AD; Kovatich AJ; Benz CC; Levine DA; Lee AV
  • Comprehensive Characterization of Cancer Driver Genes and Mutations.
    Cell Volume: 173 Page(s): 371 - 385.e18
    04/05/2018 Authors: Bailey MH; Tokheim C; Porta-Pardo E; Sengupta S; Bertrand D; Weerasinghe A; Colaprico A; Wendl MC; Kim J; Reardon B
  • Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types.
    Cell Rep Volume: 23 Page(s): 282 - 296.e4
    04/03/2018 Authors: Seiler M; Peng S; Agrawal AA; Palacino J; Teng T; Zhu P; Smith PG; Cancer Genome Atlas Research Network; Buonamici S; Yu L
  • Systematic Analysis of Splice-Site-Creating Mutations in Cancer.
    Cell Rep Volume: 23 Page(s): 270 - 281.e3
    04/03/2018 Authors: Jayasinghe RG; Cao S; Gao Q; Wendl MC; Vo NS; Reynolds SM; Zhao Y; Climente-Gonzlez H; Chai S; Wang F
  • Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.
    Cell Rep Volume: 23 Page(s): 172 - 180.e3
    04/03/2018 Authors: Way GP; Sanchez-Vega F; La K; Armenia J; Chatila WK; Luna A; Sander C; Cherniack AD; Mina M; Ciriello G
  • Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types.
    Cell Rep Volume: 23 Page(s): 213 - 226.e3
    04/03/2018 Authors: Ge Z; Leighton JS; Wang Y; Peng X; Chen Z; Chen H; Sun Y; Yao F; Li J; Zhang H
  • Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.
    Cell Rep Volume: 23 Page(s): 239 - 254.e6
    04/03/2018 Authors: Knijnenburg TA; Wang L; Zimmermann MT; Chambwe N; Gao GF; Cherniack AD; Fan H; Shen H; Way GP; Greene CS
  • Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.
    Cell Rep Volume: 23 Page(s): 194 - 212.e6
    04/03/2018 Authors: Campbell JD; Yau C; Bowlby R; Liu Y; Brennan K; Fan H; Taylor AM; Wang C; Walter V; Akbani R
  • Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers.
    Cell Rep Volume: 23 Page(s): 255 - 269.e4
    04/03/2018 Authors: Peng X; Chen Z; Farshidfar F; Xu X; Lorenzi PL; Wang Y; Cheng F; Tan L; Mojumdar K; Du D
  • Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.
    Cell Rep Volume: 23 Page(s): 227 - 238.e3
    04/03/2018 Authors: Gao Q; Liang W-W; Foltz SM; Mutharasu G; Jayasinghe RG; Cao S; Liao W-W; Reynolds SM; Wyczalkowski MA; Yao L
  • Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context.
    Cell Rep Volume: 23 Page(s): 297 - 312.e12
    04/03/2018 Authors: Chiu H-S; Somvanshi S; Patel E; Chen T-W; Singh VP; Zorman B; Patil SL; Pan Y; Chatterjee SS; Cancer Genome Atlas Research Network
  • The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
    Cell Rep Volume: 23 Page(s): 313 - 326.e5
    04/03/2018 Authors: Ricketts CJ; De Cubas AA; Fan H; Smith CC; Lang M; Reznik E; Bowlby R; Gibb EA; Akbani R; Beroukhim R
  • Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images.
    Cell Rep Volume: 23 Page(s): 181 - 193.e7
    04/03/2018 Authors: Saltz J; Gupta R; Hou L; Kurc T; Singh P; Nguyen V; Samaras D; Shroyer KR; Zhao T; Batiste R
  • Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung.
    Volume: 126 Page(s): 236 - 242
    04/01/2018 Authors: Hanley KZ; Dureau ZJ; Cohen C; Shin DM; Owonikoko TK; Sica GL
  • The Effect of Hospital Volume and Insurance Status on Overall Survival in Sinonasal Carcinoma: A National Cancer Database (NCDB) Analysis
    Volume: 100 Page(s): 1385 - 1386
    04/01/2018 Authors: Trivedi S; Switchenko J; Patel MR; Steuer C; El-Deiry MW; Higgins KA; Solares CA; McDonald MW; Shin DM; Gillespie T
  • Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines.
    Cell Syst Volume: 6 Page(s): 271 - 281.e7
    03/28/2018 Authors: Ellrott K; Bailey MH; Saksena G; Covington KR; Kandoth C; Stewart C; Hess J; Ma S; Chiotti KE; McLellan M
  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.
    Cell Syst Volume: 6 Page(s): 282 - 300.e2
    03/28/2018 Authors: Schaub FX; Dhankani V; Berger AC; Trivedi M; Richardson AB; Shaw R; Zhao W; Zhang X; Ventura A; Liu Y
  • A Correlative Analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 Expression in Oropharyngeal Squamous Cell Carcinoma.
    Mol Cancer Ther Volume: 17 Page(s): 710 - 716
    03/01/2018 Authors: Steuer CE; Griffith CC; Nannapaneni S; Patel MR; Liu Y; Magliocca KR; El-Deiry MW; Cohen C; Owonikoko TK; Shin DM
  • Visualization of the Cellular Uptake and Trafficking of DNA Origami Nanostructures in Cancer Cells.
    J Am Chem Soc Volume: 140 Page(s): 2478 - 2484
    02/21/2018 Authors: Wang P; Rahman MA; Zhao Z; Weiss K; Zhang C; Chen Z; Hurwitz SJ; Chen ZG; Shin DM; Ke Y
  • Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.
    Clin Cancer Res Volume: 24 Page(s): 858 - 869
    02/15/2018 Authors: Wang X; Beitler JJ; Huang W; Chen G; Qian G; Magliocca K; Patel MR; Chen AY; Zhang J; Nannapaneni S
  • HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancers.
    Oral Oncol Volume: 77 Page(s): 92 - 97
    02/01/2018 Authors: Pai SI; Jack Lee J; Carey TE; Westra WH; Ferrone S; Moore C; Mosunjac MB; Shin DM; Ferris RL; HNC SPORE HIV supplement consortium
  • Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Cancer Volume: 124 Page(s): 84 - 94
    01/01/2018 Authors: Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN
  • Systemic Delivery of Bc12-Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth.
    Angew Chem Int Ed Engl Volume: 56 Page(s): 16023 - 16027
    12/11/2017 Authors: Rahman MA; Wang P; Zhao Z; Wang D; Nannapaneni S; Zhang C; Chen Z; Griffith CC; Hurwitz SJ; Chen ZG
  • Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.
    Head Neck Volume: 39 Page(s): 2433 - 2443
    12/01/2017 Authors: Zhang H; Kim S; Chen Z; Nannapaneni S; Chen AY; Moore CE; Sica G; Mosunjac M; Nguyen MLT; D'Souza G
  • HPV status is associated with fatigue at one year post IMRT for patients with head and neck cancer
    Volume: 26 Page(s): 45 - 45
    10/01/2017 Authors: Xiao C; Beitler JJ; Higgins KA; Saba NF; Shin DM; Linh KH; Glazer T; Miller AH; Bruner DW
  • Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
    Cancer Volume: 123 Page(s): 3476 - 3485
    09/15/2017 Authors: Naik KB; Liu Y; Goodman M; Gillespie TW; Pickens A; Force SD; Steuer CE; Owonikoko TK; Ramalingam SS; Higgins K
  • Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status.
    Oncotarget Volume: 8 Page(s): 59008 - 59022
    08/29/2017 Authors: Zhang J; Nannapaneni S; Wang D; Liu F; Wang X; Jin R; Liu X; Rahman MA; Peng X; Qian G
  • Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic Review.
    JAMA Oncol Volume: 3 Page(s): 1120 - 1129
    08/01/2017 Authors: Steuer CE; Behera M; Ernani V; Higgins KA; Saba NF; Shin DM; Pakkala S; Pillai RN; Owonikoko TK; Curran WJ
  • Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis.
    Oncogene Volume: 36 Page(s): 3797 - 3806
    07/06/2017 Authors: Jin L; Chun J; Pan C; Alesi GN; Li D; Magliocca KR; Kang Y; Chen ZG; Shin DM; Khuri FR
  • Modulation of Bax and mTOR for cancer therapeutics
    Volume: 77
    07/01/2017 Authors: Li R; Ding C; Zhang J; Xie M; Park D; Ding Y; Chen G; Zhang G; Gilbert-Ross M; Zhou W
  • Modulation of Bax and mTOR for Cancer Therapeutics.
    Cancer Res Volume: 77 Page(s): 3001 - 3012
    06/01/2017 Authors: Li R; Ding C; Zhang J; Xie M; Park D; Ding Y; Chen G; Zhang G; Gilbert-Ross M; Zhou W
  • Measurement of Circulating Tumors Cells in Squamous Cell Carcinoma of the Head and Neck and Patient Outcomes
    Volume: 98 Page(s): E9 - E9
    06/01/2017 Authors: Morgan T; Wang X; Qian X; Nie S; Shin DM; Beitler JJ
  • Institutional treatment volume and outcomes in salivary gland cancer.
    Volume: 35
    05/20/2017 Authors: Steuer CE; Switchenko JM; Griffith CC; Patel M; Cassidy RJ; Gillespie TW; McDonald MW; Higgins KA; Beitler JJ; Owonikoko TK
  • Small cell carcinoma of the head and neck: Incidence and survival trends based on the Surveillance and Epidemiologic and End Results (SEER) analysis.
    Volume: 35
    05/20/2017 Authors: Bean M; Goodman M; Steuer CE; Patel M; McDonald MW; Higgins KA; Owonikoko TK; Beitler JJ; Shin DM; Saba NF
  • Phase IB study of induction chemotherapy with XELOX, followed by radiation therapy, carboplatin, and everolimus in patients with locally advanced esophageal cancer (EC).
    Volume: 35
    05/20/2017 Authors: Saba NF; Force SD; Staley CA; Fernandez FG; Willingham FF; Allan P; Cardona K; Chen Z; Cardin DB; Lambright E
  • Intact APM and PD-1:PD-L1 pathway upregulation in HIV-infected head and neck cancer patients.
    Volume: 35
    05/20/2017 Authors: Pal SI; Lee JJ; Carey TE; Westra WH; Ferrone S; Moore C; Shin DM; Ferris RL
  • Association of Cytoplasmic CXCR4 With Loss of Epithelial Marker and Activation of ERK1/2 and AKT Signaling Pathways in Non-Small-Cell LungCancer.
    Clin Lung Cancer Volume: 18 Page(s): e203 - e210
    05/01/2017 Authors: Saba NF; Wang Y; Fu H; Koenig L; Khuri FR; Shin DM; Chen ZG
  • Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base.
    Volume: 18 Page(s): 286 - 292
    05/01/2017 Authors: Steuer CE; Behera M; Liu Y; Fu C; Gillespie TW; Saba NF; Shin DM; Pillai RN; Pakkala S; Owonikoko TK
  • Efficacy, long-term toxicity, and mechanistic studies of gold nanorods photothermal therapy of cancer in xenograft mice.
    Proc Natl Acad Sci U S A Volume: 114 Page(s): E3110 - E3118
    04/11/2017 Authors: Ali MRK; Rahman MA; Wu Y; Han T; Peng X; Mackey MA; Wang D; Shin HJ; Chen ZG; Xiao H
  • In Vitro and In Vivo Synergistic Antitumor Activity of the Combination of BKM120 and Erlotinib in Head and Neck Cancer: Mechanism of Apoptosis and Resistance.
    Mol Cancer Ther Volume: 16 Page(s): 729 - 738
    04/01/2017 Authors: Anisuzzaman ASM; Haque A; Wang D; Rahman MA; Zhang C; Chen Z; Chen ZG; Shin DM; Amin ARMR
  • Multiple biological functions of Twist1 in various cancers.
    Oncotarget Volume: 8 Page(s): 20380 - 20393
    03/21/2017 Authors: Zhao Z; Rahman MA; Chen ZG; Shin DM
  • High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV.
    Mol Cancer Res Volume: 15 Page(s): 179 - 188
    02/01/2017 Authors: Walline HM; Carey TE; Goudsmit CM; Bellile EL; D'Souza G; Peterson LA; McHugh JB; Pai SI; Lee JJ; Shin DM
  • HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models.
    Clin Cancer Res Volume: 23 Page(s): 677 - 686
    02/01/2017 Authors: Wang D; Qian G; Zhang H; Magliocca KR; Nannapaneni S; Amin ARMR; Rossi M; Patel M; El-Deiry M; Wadsworth JT
  • Adenosquamous Carcinoma of the Esophagus: An NCDB-Based Investigation on Comparative Features and Overall Survival in a Rare Tumor.
    Oncology Volume: 93 Page(s): 336 - 342
    01/01/2017 Authors: Evans M; Liu Y; Chen C; Steuer C; Cassidy R; Landry J; Higgins K; Beitler JJ; Willingham F; Owonikoko TK
  • Trends, Patterns of Treatment and Outcomes in Non-Small Cell Lung Cancer (NSCLC) as a Second Primary: A National Cancer Data Base (NCDB) Analysis
    Volume: 12 Page(s): S470 - S470
    01/01/2017 Authors: Behera M; Gillespie T; Liu Y; Jia Y; Higgins K; Steuer C; Saba N; Shin D; Pakkala S; Pillai R
  • RSK2 signals through stathmin to promote microtubule dynamics and tumor metastasis.
    Oncogene Volume: 35 Page(s): 5412 - 5421
    10/13/2016 Authors: Alesi GN; Jin L; Li D; Magliocca KR; Kang Y; Chen ZG; Shin DM; Khuri FR; Kang S
  • Zolpidem use and risk of fractures: a systematic review and meta-analysis.
    Osteoporos Int Volume: 27 Page(s): 2935 - 2944
    10/01/2016 Authors: Park SM; Ryu J; Lee DR; Shin D; Yun JM; Lee J
  • Persistent Fatigue Is Associated With Persistent Peripheral Inflammation in Patients With Squamous Cell Carcinoma of the Head and Neck Cancer up to 3 Months Post-Intensity Modulated Radiation Therapy
    Volume: 96 Page(s): E348 - E348
    10/01/2016 Authors: Xiao C; Beitler JJ; Higgins KA; Glazer T; Wommack E; Shin DM; Saba NF; Bruner DW; Miller AH
  • Persistent Fatigue Is Associated With Persistent Peripheral Inflammation in Patients With Squamous Cell Carcinoma of the Head and Neck Cancer up to 3 Months Post-Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys Volume: 96 Page(s): E348
    10/01/2016 Authors: Xiao C; Beitler JJ; Higgins KA; Glazer T; Wommack E; Shin DM; Saba NF; Watkins Bruner D; Miller AH
  • Human papillomavirus oncoprotein E6 upregulates c-Met through p53 downregulation.
    Eur J Cancer Volume: 65 Page(s): 21 - 32
    09/01/2016 Authors: Qian G; Wang D; Magliocca KR; Hu Z; Nannapaneni S; Kim S; Chen Z; Sun S-Y; Shin DM; Saba NF
  • The Challenges of Laryngeal Preservation-Is It the Systemic Agent or the Proper Sequence of Therapy?
    JAMA Otolaryngol Head Neck Surg Volume: 142 Page(s): 849 - 850
    09/01/2016 Authors: Saba NF; Shin DM
  • Biomarker quantification by multiplexed quantum dot technology for predicting lymph node metastasis and prognosis in head and neck cancer.
    Oncotarget Volume: 7 Page(s): 44676 - 44685
    07/12/2016 Authors: Hu Z; Qian G; Mller S; Xu J; Saba NF; Kim S; Chen Z; Jiang N; Wang D; Zhang H
  • Soy isoflavones modulate global methylation in head and neck squamous cell carcinoma (HNSCC)
    Volume: 76
    07/01/2016 Authors: Rozek L; Virani S; Bellile E; Taylor J; Sartor M; Virani A; Rentschler K; Cote C; Worden F; Peterson L
  • Survivin contributes to radiation resistance in head and neck cancer through regulation of DNA damage repair
    Volume: 76
    07/01/2016 Authors: Wang X; Beitler JJ; Huang W; Chen G; Nannapaneni S; Saba NF; Deng X; Chen ZG; Shin DM
  • Optimizing the antitumor efficacy of AuNR-assisted plasmonic photothermal therapy and its molecular impact
    Volume: 76
    07/01/2016 Authors: Rahman MA; Ali MRK; Zhao Z; Chen GZ; El-Sayed MA; Shin DM
  • HER3 targeting sensitizes HNSCC to cetuximab - evidence from cell line and patient derived xenograft (PDX) models
    Volume: 76
    07/01/2016 Authors: Wang D; Qian G; Zhang H; Magliocca KR; Nannapaneni S; Chen Z; Patel MR; El-Deiry MW; Wadsworth JT; Shin DM
  • A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular -catenin expression.
    J Oral Pathol Med Volume: 45 Page(s): 399 - 408
    07/01/2016 Authors: Qian G; Hu Z; Xu H; Mller S; Wang D; Zhang H; Kim S; Chen Z; Saba NF; Shin DM
  • Clinical outcomes in elderly patients with human papillomavirus-positive squamous cell carcinoma of the oropharynx treated with definitive chemoradiation therapy.
    Head Neck Volume: 38 Page(s): 846 - 851
    06/01/2016 Authors: Hanasoge S; Magliocca KR; Switchenko JM; Saba NF; Wadsworth JT; El-Deiry MW; Shin DM; Khuri F; Beitler JJ; Higgins KA
  • Anticancer activity of drug conjugates in head and neck cancer cells.
    Front Biosci (Elite Ed) Volume: 8 Page(s): 358 - 369
    06/01/2016 Authors: Majumdar D; Rahman MA; Chen ZG; Shin DM
  • Comparative features and overall survival in adenosquamous carcinoma, a rare tumor of the esophagus.
    Volume: 34
    05/20/2016 Authors: Evans M; Liu Y; Chen C; Gillespie TW; Steuer CE; Owonikoko TK; Ramalingam SS; Beitler JJ; El-Rayes BF; Fernandez F
  • Effect of definitive concurrent therapy with or without surgery on resectable esophageal cancer survival: An analysis of the National Cancer Data Base
    Volume: 34
    05/20/2016 Authors: Naik K; Liu Y; Goodman M; Gillespie TW; El-Rayes BF; Pickens A; Force S; Steuer CE; Owonikoko TK; Ramalingam SS
  • Non-small cell lung cancer (NSCLC) as a second primary: Analysis of the National Cancer Data Base (NCDB).
    Volume: 34
    05/20/2016 Authors: Behera M; Gillespie TW; Liu Y; Jia Y; Higgins KA; Steuer CE; Saba NF; Shin DM; Pakkala S; Pillai RN
  • A correlative analysis of PDL-1, PD-1, and EGFR, HER2, HER3 expression in oropharyngeal squamous cell carcinoma (OPSCC).
    Volume: 34
    05/20/2016 Authors: Steuer CE; Griffith CC; Liu Y; Magliocca KR; Patel M; Cohen C; Owonikoko TK; Shin DM; Chen ZG; Saba NF
  • An integrated workflow to identify targetable mutations in FFPE samples of HNSCC.
    Volume: 34
    05/20/2016 Authors: Saba NF; Magliocca KR; Patel M; Steuer CE; Newman S; Zhang H; El-Deiry M; Wadsworth JT; Kowalski J; Shin DM
  • Mannitol to prevent cisplatin-induced nephrotoxicity in patients with squamous cell cancer of the head and neck (SCCHN) receiving concurrent therapy.
    Support Care Cancer Volume: 24 Page(s): 1789 - 1793
    04/01/2016 Authors: McKibbin T; Cheng LL; Kim S; Steuer CE; Owonikoko TK; Khuri FR; Shin DM; Saba NF
  • RSK2 signals through stathmin to promote microtubule dynamics and tumor metastasis
    Volume: 76
    04/01/2016 Authors: Alesi G; Jin L; Li D; Magliocca K; Kang Y; Chen ZG; Shin DM; Khuri FR; Kang S
  • Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.
    JAMA Oncol Volume: 2 Page(s): 209 - 216
    02/01/2016 Authors: William WN; Papadimitrakopoulou V; Lee JJ; Mao L; Cohen EEW; Lin HY; Gillenwater AM; Martin JW; Lingen MW; Boyle JO
  • Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy.
    Brain Behav Immun Volume: 52 Page(s): 145 - 152
    02/01/2016 Authors: Xiao C; Beitler JJ; Higgins KA; Conneely K; Dwivedi B; Felger J; Wommack EC; Shin DM; Saba NF; Ong LY
  • Association between Sleep Duration and Measurable Cardiometabolic Risk Factors in Healthy Korean Women: The Fourth and Fifth Korean National Health and Nutrition Examination Surveys (KNHANES IV and V).
    Int J Endocrinol Volume: 2016 Page(s): 3784210
    01/01/2016 Authors: Min H; Um YJ; Jang BS; Shin D; Choi E; Park SM; Lee K
  • Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunities.
    Acta Biochim Biophys Sin (Shanghai) Volume: 48 Page(s): 11 - 16
    01/01/2016 Authors: Zhang J; Park D; Shin DM; Deng X
  • Preclinical In Vitro, In Vivo, and Pharmacokinetic Evaluations of FLLL12 for the Prevention and Treatment of Head and Neck Cancers.
    Cancer Prev Res (Phila) Volume: 9 Page(s): 63 - 73
    01/01/2016 Authors: Anisuzzaman ASM; Haque A; Rahman MA; Wang D; Fuchs JR; Hurwitz S; Liu Y; Sica G; Khuri FR; Chen ZG
  • Antitumor Activity of 2,9-Di-Sec-Butyl-1,10-Phenanthroline.
    PLoS One Volume: 11 Page(s): e0168450
    01/01/2016 Authors: Wang D; Peng S; Amin ARMR; Rahman MA; Nannapaneni S; Liu Y; Shin DM; Saba NF; Eichler JF; Chen ZG
  • Development of Late Toxicities in Patients with Oral Tongue Cancer Treated with Surgical Resection and Adjuvant Radiation Therapy.
    Front Oncol Volume: 6 Page(s): 272
    01/01/2016 Authors: Sayan M; Cassidy RJ; Switchenko JM; Kayode OA; Saba NF; Steuer CE; Shin DM; Wadsworth JT; El-Deiry M; Patel M
  • Designing a broad-spectrum integrative approach for cancer prevention and treatment.
    Semin Cancer Biol Volume: 35 Suppl Page(s): S276 - S304
    12/01/2015 Authors: Block KI; Gyllenhaal C; Lowe L; Amedei A; Amin ARMR; Amin A; Aquilano K; Arbiser J; Arreola A; Arzumanyan A
  • Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.
    Semin Cancer Biol Volume: 35 Suppl Page(s): S55 - S77
    12/01/2015 Authors: Amin ARMR; Karpowicz PA; Carey TE; Arbiser J; Nahta R; Chen ZG; Dong J-T; Kucuk O; Khan GN; Huang GS
  • HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells.
    Carcinogenesis Volume: 36 Page(s): 1397 - 1406
    11/01/2015 Authors: Marullo R; Werner E; Zhang H; Chen GZ; Shin DM; Doetsch PW
  • Targeting HER (ERBB) signaling in head and neck cancer: An essential update.
    Mol Aspects Med Volume: 45 Page(s): 74 - 86
    11/01/2015 Authors: Zhang J; Saba NF; Chen GZ; Shin DM
  • CCR 20th Anniversary Commentary: Prospects and Challenges of Therapeutic Nanoparticles in Cancer.
    Clin Cancer Res Volume: 21 Page(s): 4499 - 4501
    10/15/2015 Authors: Rahman MA; Shin DM
  • Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
    Cancer Volume: 121 Page(s): 3600 - 3611
    10/15/2015 Authors: Qian G; Jiang N; Wang D; Newman S; Kim S; Chen Z; Garcia G; MacBeath G; Shin DM; Khuri FR
  • A Systematic Review of Carboplatin-Paclitaxel versus Cisplatin-Etoposide Concurrent with Thoracic Radiation for Stage III NSCLC Patients
    JOURNAL OF THORACIC ONCOLOGY Volume: 10 Page(s): S212 - S212
    09/01/2015 Authors: Steuer C; Behera M; Higgins KA; Saba N; Shin D; Pakkala S; Pillai R; Owonikoko TK; Curran WJ; Belani CP
  • Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth
    Volume: 75
    08/01/2015 Authors: Jin L; Li D; Alesi G; Fan J; Kang H-B; Zhou L; Boggon T; Magliocca K; He C; Arellano M
  • Potent curcumin analog FLLL12 induces apoptosis in lung cancer cells through death receptor-5-dependent pathway
    Volume: 75
    08/01/2015 Authors: Haque A; Rahman MA; Fuchs JR; Clien ZG; Khuri FR; Shin DM; Amin ARMR
  • The nuclear-targeted gold nanoparticles inhibit the tumor growth in mouse model as potential anticancer agents
    Volume: 75
    08/01/2015 Authors: Peng X; Macke MA; Shin HJC; Nannapaneni S; Chen N; Kim S; Chen ZG; El-Sayed MA; Shin D
  • Human papillomavirus 16 oncoprotein E6 upregulates c-Met partially through p53 in squamous cell carcinoma of the head and neck
    Volume: 75
    08/01/2015 Authors: Qian G; Wang D; Magliocca KR; Duggal P; Nannapaneni S; Kim S; Chen Z; Shin DM; Saba NF; Chen ZG
  • Targeting RRM2 by siRNA inhibits cellular invasion and represents a rational approach for inhibition of metastasis of head and neck and lung cancers
    Volume: 75
    08/01/2015 Authors: Rahman MA; Amin ARMR; Zhang J; Nannapaneni S; Saba NF; Chen ZG; Shin DM
  • Canine spontaneous head and neck squamous cell carcinomas represent their human counterparts at the molecular level
    Volume: 75
    08/01/2015 Authors: Liu D; Xiong H; Ellis AE; Northrup NC; Shin DM; Zhao S
  • Honokiol radiosensitizes squamous cells carcinoma of head and neck by down-regulation of survivin
    Volume: 75
    08/01/2015 Authors: Wang X; Beitler JJ; Huang W; Qian G; Magliocca K; Zhang J; Nannapaneni S; Kim S; Chen Z; Nabil SF
  • FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway.
    Cancer Lett Volume: 363 Page(s): 166 - 175
    07/28/2015 Authors: Haque A; Rahman MA; Fuchs JR; Chen ZG; Khuri FR; Shin DM; Amin ARMR
  • Combination of erlotinib and EGCG induces apoptosis of head and neck cancers through posttranscriptional regulation of Bim and Bcl-2.
    Apoptosis Volume: 20 Page(s): 986 - 995
    07/01/2015 Authors: Haque A; Rahman MA; Chen ZG; Saba NF; Khuri FR; Shin DM; Ruhul Amin ARM
  • Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy.
    Cancer Cell Volume: 27 Page(s): 852 - 863
    06/08/2015 Authors: Han B; Park D; Li R; Xie M; Owonikoko TK; Zhang G; Sica GL; Ding C; Zhou J; Magis AT
  • Racial disparities in squamous cell carcinoma of the oral tongue among women: a SEER data analysis.
    Oral Oncol Volume: 51 Page(s): 586 - 592
    06/01/2015 Authors: Joseph LJ; Goodman M; Higgins K; Pilai R; Ramalingam SS; Magliocca K; Patel MR; El-Deiry M; Wadsworth JT; Owonikoko TK
  • Canine spontaneous head and neck squamous cell carcinomas represent their human counterparts at the molecular level.
    PLoS Genet Volume: 11 Page(s): e1005277
    06/01/2015 Authors: Liu D; Xiong H; Ellis AE; Northrup NC; Dobbin KK; Shin DM; Zhao S
  • Landscape of genetic alterations in non-smoking patients with oral tongue carcinoma: An analysis of The Cancer Genome Atlas (TCGA) head and neck squamous cell carcinoma data
    Volume: 33
    05/20/2015 Authors: Saba NF; Newman S; Rossi MR; Steuer CE; Zhang H; Patel M; Wadsworth JT; El-Deiry M; Magliocca KR; Owonikoko TK
  • Trimodality therapy in the treatment of stage IIIA non-small cell lung cancer (NSCLC): Analysis of the National Cancer Database.
    Volume: 33
    05/20/2015 Authors: Behera M; Steuer CE; Fernandez F; Liu Y; Fu C; Gillespie TW; Higgins KA; Saba NF; Pillai RN; Force S
  • Dual targeting of EGFR and HER3 with cetuximab and MM-121/SAR256212 in HNSCC patient derived xenograft (PDX) models.
    Volume: 33
    05/20/2015 Authors: Saba NF; Wang D; Qian G; Zhang H; Patel M; El-Deiry M; Wadsworth JT; Magliocca KR; Nannapaneni S; Shin DM
  • Pemetrexed versus taxane-containing platinum doublet therapy for advanced non-squamous non-small cell lung cancer (NSCLC): A systematic analysis.
    Volume: 33
    05/20/2015 Authors: Behera M; Pillai RN; Owonikoko TK; Pakkala S; Steuer CE; Saba NF; Shin DM; Belani CP; Khuri FR; Ramalingam SS
  • Targeting KRAS mutant non-small cell lung cancer (NSCLC) with deltarasin: A small molecule inhibitor of KRAS-PDE delta interaction.
    Volume: 33
    05/20/2015 Authors: Zhang J; Xu K; Shin DM; Deng X
  • Predictors and outcomes of venous thromboembolism in hospitalized lung cancer patients: A Nationwide Inpatient Sample database analysis.
    Lung Cancer Volume: 88 Page(s): 80 - 84
    04/01/2015 Authors: Steuer CE; Behera M; Kim S; Patel N; Chen Z; Pillai R; Saba NF; Shin DM; Owonikoko TK; Khuri FR
  • Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth.
    Cancer Cell Volume: 27 Page(s): 257 - 270
    02/09/2015 Authors: Jin L; Li D; Alesi GN; Fan J; Kang H-B; Lu Z; Boggon TJ; Jin P; Yi H; Wright ER
  • Human papillomavirus 16 oncoprotein regulates the translocation of -catenin via the activation of epidermal growth factor receptor.
    Cancer Volume: 121 Page(s): 214 - 225
    01/15/2015 Authors: Hu Z; Mller S; Qian G; Xu J; Kim S; Chen Z; Jiang N; Wang D; Zhang H; Saba NF
  • Curcumin induces apoptosis of upper aerodigestive tract cancer cells by targeting multiple pathways.
    PLoS One Volume: 10 Page(s): e0124218
    01/01/2015 Authors: Amin ARMR; Haque A; Rahman MA; Chen ZG; Khuri FR; Shin DM
  • Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck.
    Cancer Volume: 120 Page(s): 3940 - 3951
    12/15/2014 Authors: Saba NF; Hurwitz SJ; Magliocca K; Kim S; Owonikoko TK; Harvey D; Ramalingam SS; Chen Z; Rogerio J; Mendel J
  • Patients' perceptions of complementary and alternative medicine in head and neck cancer: a qualitative, pilot study with clinical implications.
    Complement Ther Clin Pract Volume: 20 Page(s): 213 - 218
    11/01/2014 Authors: Hendershot KA; Dixon M; Kono SA; Shin DM; Pentz RD
  • The plasmonic photothermal therapy efficacy of Au NRs in vivo using a SCCHN xenograft mouse model
    Volume: 74
    10/01/2014 Authors: Peng X; Mackey MA; Oyelere A; Zhang J; Chen G; Nie S; El-Sayed MA; Shin DM
  • Enhancing specificity in predication of human papillomavirus associated oropharyngeal squamous cell carcinoma by combining biomarkers p16 and beta-catenin
    Volume: 74
    10/01/2014 Authors: Qian G; Xu H; Hu Z; Kim S; Wang D; Zhang H; Chen Z; Muller S; Saba N; Shin DM
  • Evaluation prognostic significance of circulating tumor cells (CTCs) using multiplexed gold nanoparticles in patients with head and neck cancer
    Volume: 74
    10/01/2014 Authors: Wang X; Qian X; Beitler JJ; Zhang J; Kang H; Chen ZG; Magliocca KR; Wang X; Chen Z; Nie S
  • EGFR targeted iron-oxide nanoparticles for photodynamic therapy in head and neck cancer
    Volume: 74
    10/01/2014 Authors: Wang D; Qin X; Qian G; Halig L; Fei B; Chen Z; Chen ZG; Saba NF; Shin DM; Xu H
  • Combination of erlotinib and epigallocatechin-3-gallate induces apoptosis of squamous cell carcinoma of the head and neck through posttranslational regulation of Bim and Bcl-2
    Volume: 74
    10/01/2014 Authors: Haque A; Rahman MA; Chen ZG; Shin DM; Amin ARMR
  • Ribonucleotide reductase subunit M2 plays important role in cisplatin resistance of cancer cells
    Volume: 74
    10/01/2014 Authors: Rahman MA; Amin ARMR; Peng X; Zhang J; Chen ZG; Shin DM
  • Potent curcumin analog FLLL-12 targets both intrinsic and extrinsic signaling pathways to induce apoptosis in lung cancers
    Volume: 74
    10/01/2014 Authors: Amin ARMR; Haque A; Rahman MA; Fuchs JR; Chen ZG; Shin DM
  • RSK2-mediated phosphorylation of stathmin promotes microtubule polymerization, providing a pro-invasive advantage to metastatic cancer cells
    Volume: 74
    10/01/2014 Authors: Alesi G; Li D; Jin L; Chen GZ; Shin DM; Khuri F; Kang S
  • Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303.
    Clin Cancer Res Volume: 20 Page(s): 5041 - 5051
    10/01/2014 Authors: Egloff AM; Lee J-W; Langer CJ; Quon H; Vaezi A; Grandis JR; Seethala RR; Wang L; Shin DM; Argiris A
  • Increased Fatigue Is Associated With TNF and NF kappa B-Regulated Inflammatory Signaling in Patients With Head and Neck Cancer Receiving IMRT
    Volume: 90 Page(s): S571 - S571
    09/01/2014 Authors: Xiao C; Beitler JJ; Higgins KA; Felger J; Ong LY; Shin DM; Saba NF; Bruner DW; Miller AH
  • Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced squamous cell carcinomas of the head and neck (SCCHN): a systematic review.
    Oral Oncol Volume: 50 Page(s): 888 - 894
    09/01/2014 Authors: Behera M; Owonikoko TK; Kim S; Chen Z; Higgins K; Ramalingam SS; Shin DM; Khuri FR; Beitler JJ; Saba NF
  • Tyr-94 phosphorylation inhibits pyruvate dehydrogenase phosphatase 1 and promotes tumor growth.
    J Biol Chem Volume: 289 Page(s): 21413 - 21422
    08/01/2014 Authors: Shan C; Kang H-B; Elf S; Xie J; Gu T-L; Aguiar M; Lonning S; Hitosugi T; Chung T-W; Arellano M
  • Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer.
    ACS Nano Volume: 8 Page(s): 6620 - 6632
    07/22/2014 Authors: Wang D; Fei B; Halig LV; Qin X; Hu Z; Xu H; Wang YA; Chen Z; Kim S; Shin DM
  • Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma.
    Mol Cancer Ther Volume: 13 Page(s): 1826 - 1836
    07/01/2014 Authors: Jiang N; Wang D; Hu Z; Shin HJC; Qian G; Rahman MA; Zhang H; Amin ARMR; Nannapaneni S; Wang X
  • Coffee consumption and risk of fractures: a systematic review and dose-response meta-analysis.
    Bone Volume: 63 Page(s): 20 - 28
    06/01/2014 Authors: Lee DR; Lee J; Rota M; Lee J; Ahn HS; Park SM; Shin D
  • Transcriptional profiling of Tu212 cell line treated with EGCG and resveratrol to identify actionable targets for adjuvant therapy
    Volume: 32
    05/20/2014 Authors: Shin DM; Dwivedi B; Amin RARM; Haque AM; Saba NF; Rossl MR; Chen ZG; Kowalski J
  • Phenformin combines with selumetinib in targeting KRAS mutant non-small cell lung cancer cells with alternative LKB1 status.
    Volume: 32
    05/20/2014 Authors: Zhang J; Wang D; Qian G; Liu F; Rahman MA; Nannapaneni S; Wang X; Peng X; Chen ZG; Wong K-K
  • Expressions of EGFR, HER2, and HER3 and their correlations with clinical characteristics in oropharyngeal squamous cell carcinoma (OPSCC).
    Volume: 32
    05/20/2014 Authors: Saba NF; Qian G; Ning J; Kim S; Chen Z; Garcia G; MacBeath G; Shin DM; Khuri FR; Chen ZG
  • Predictors and outcomes of venous thromboembolism (VTE) in hospitalized lung cancer patients: A nationwide inpatient sample (NIS) database analysis
    Volume: 32
    05/20/2014 Authors: Steuer CE; Behera M; Kim S; Patel N; Chen Z; Pillai RN; Saba NF; Shin DM; Owonlkoko TK; Khuri FR
  • Predictive value of gene expression signatures in premalignant lesions of the head and neck for response to cheinoprevention with EGFR and COX-2 inhibitors.
    Volume: 32
    05/20/2014 Authors: Saba NF; Rossi MR; Dwivedi B; Switchenko JM; Magllocca KR; Ramalingam SS; Owonlkoko TK; Khuri FR; Chen ZG; Kowalski J
  • Racial disparities in the incidence and survival trends in women with squamous cell carcinoma of the oral tongue based on the Surveillance, Epidemiology, and End Results (SEER) analysis.
    Volume: 32
    05/20/2014 Authors: Joseph L; Goodman M; Higgins KA; Pilai R; Ramalingam SS; Owonikoko TK; Beitler JJ; Shin DM; Khuri FR; Saba NF
  • Expression of tumor biomarkers in HIV-infected patients with head and neck cancer.
    Volume: 32
    05/20/2014 Authors: Zhang H; Kim S; Chen Z; Nannapaneni S; Sica G; Carey TE; William WN; Minh LN; Riddell J; Pal SI
  • Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancer.
    Cancer Volume: 120 Page(s): 1394 - 1400
    05/01/2014 Authors: Kang H; Gillespie TW; Goodman M; Brodie SA; Brandes M; Ribeiro M; Ramalingam SS; Shin DM; Khuri FR; Brandes JC
  • Epidemiology of head and neck squamous cell cancer among HIV-infected patients.
    J Acquir Immune Defic Syndr Volume: 65 Page(s): 603 - 610
    04/15/2014 Authors: Dsouza G; Carey TE; William WN; Nguyen ML; Ko EC; Riddell J; Pai SI; Gupta V; Walline HM; Lee JJ
  • Acetylated tubulin (AT) as a prognostic marker in squamous cell carcinoma of the head and neck.
    Head Neck Pathol Volume: 8 Page(s): 66 - 72
    03/01/2014 Authors: Saba NF; Magliocca KR; Kim S; Muller S; Chen Z; Owonikoko TK; Sarlis NJ; Eggers C; Phelan V; Grist WJ
  • Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study.
    Cancer Prev Res (Phila) Volume: 7 Page(s): 283 - 291
    03/01/2014 Authors: Saba NF; Hurwitz SJ; Kono SA; Yang CS; Zhao Y; Chen Z; Sica G; Mller S; Moreno-Williams R; Lewis M
  • Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts.
    Curr Cancer Drug Targets Volume: 14 Page(s): 380 - 393
    01/01/2014 Authors: Zhu S; Moore TW; Morii N; Howard RB; Culver D; Arrendale RF; Reddy P; Evers TJ; Zhang H; Sica G
  • Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis.
    PLoS One Volume: 9 Page(s): e86369
    01/01/2014 Authors: Wang X; Beitler JJ; Wang H; Lee MJ; Huang W; Koenig L; Nannapaneni S; Amin ARMR; Bonner M; Shin HJC
  • Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity.
    Cancer Prev Res (Phila) Volume: 7 Page(s): 65 - 73
    01/01/2014 Authors: Majumdar D; Jung K-H; Zhang H; Nannapaneni S; Wang X; Amin ARMR; Chen Z; Chen ZG; Shin DM
  • The prometastatic ribosomal S6 kinase 2-cAMP response element-binding protein (RSK2-CREB) signaling pathway up-regulates the actin-binding protein fascin-1 to promote tumor metastasis.
    J Biol Chem Volume: 288 Page(s): 32528 - 32538
    11/08/2013 Authors: Li D; Jin L; Alesi GN; Kim Y-M; Fan J; Seo JH; Wang D; Tucker M; Gu T-L; Lee BH
  • Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands.
    J Inorg Biochem Volume: 128 Page(s): 68 - 76
    11/01/2013 Authors: Sanghvi CD; Olsen PM; Elix C; Peng SB; Wang D; Chen ZG; Shin DM; Hardcastle KI; MacBeth CE; Eichler JF
  • NOX-Mediated Chronic Oxidative Stress Contributes to Genomic Instability and Radiosensitivity in Human Papillomavirus-Infected Head and Neck Cancer Cells.
    Volume: 54 Page(s): S31 - S31
    09/01/2013 Authors: Marullo R; Zhang H; Chen GZ; Shin DM; Doetsch PW
  • Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009.
    Cancer Volume: 119 Page(s): 2602 - 2610
    07/15/2013 Authors: Ansa B; Goodman M; Ward K; Kono SA; Owonikoko TK; Higgins K; Beitler JJ; Grist W; Wadsworth T; El-Deiry M
  • Paranasal Sinus Squamous Cell Carcinoma Incidence and Survival Based on Surveillance, Epidemiology, and End Results Data, 1973 to 2009
    CANCER Volume: 119 Page(s): 2602 - 2610
    07/15/2013 Authors: Ansa B; Goodman M; Ward K; Kono SA; Owonikoko TK; Higgins K; Beitler JJ; Grist W; Wadsworth T; El-Deiry M
  • RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy.
    Clin Cancer Res Volume: 19 Page(s): 3416 - 3428
    07/01/2013 Authors: Rahman MA; Amin ARMR; Wang D; Koenig L; Nannapaneni S; Chen Z; Wang Z; Sica G; Deng X; Chen ZG
  • Interruption of nuclear localization of ATBF1 during the histopathologic progression of head and neck squamous cell carcinoma.
    Head Neck Volume: 35 Page(s): 1007 - 1014
    07/01/2013 Authors: Sun X; Li J; Sica G; Fan S-Q; Wang Y; Chen Z; Muller S; Chen ZG; Fu X; Dong X-Y
  • Randomized phase II trial of cixutumumab (CIX) alone or with cetuximab (CET) for refractory recurrent/metastatic squamous cancer of head and neck (R/M-SCCHN)
    Volume: 31
    05/20/2013 Authors: Glisson BS; Tseng J; Marur S; Shin DM; Murphy BA; Cohen EEW; Thomas CY; Willey R; Cosaert J; William WN
  • Carboplatin (C), cetuximab (Cet), and everolimus (E) in recurrent or metastatic squamous cell carcinoma of the head and neck (RMSCCHN). Results of a phase Ib study.
    Volume: 31
    05/20/2013 Authors: Saba NF; Kono SA; Mendel JR; Hurwitz SJ; Owonikoko TK; Lewis CM; Harvey D; Rogerio JW; Chen Z; Wadsworth T
  • New perspectives of curcumin in cancer prevention.
    Cancer Prev Res (Phila) Volume: 6 Page(s): 387 - 400
    05/01/2013 Authors: Park W; Amin ARMR; Chen ZG; Shin DM
  • Toxicities and antitumor efficacy of tumor-targeted AuNRs in mouse model.
    Volume: 73
    04/15/2013 Authors: Peng X; Mackey M; Austin L; Oyelere A; Chen G; Huang X; El-Sayed MA; Shin DM
  • The role of nuclear factor kappa B in survival of human papillomavirus-positive head and neck cancer cell lines
    Volume: 73
    04/15/2013 Authors: Zhang H; Hu Z; Jiang N; Marullo R; Doetsch PW; Hunt WD; Chen GZ; Shin DM
  • Folate receptor targeted iron oxide nanoparticles loaded with cisplatin for imaging and therapy in head and neck squamous cell carcinoma (HNSCC)
    Volume: 73
    04/15/2013 Authors: Kang H; Huang J; Peng X; Chen ZG; Mao H; Shin DM
  • NOX-mediated chronic oxidative stress is inherent in human papillomavirus positive head and neck cancer cells and is implicated in radiosensitivity
    Volume: 73
    04/15/2013 Authors: Marullo R; Zhang H; Chen GZ; Hunt WD; Shin DM; Doetsch PW
  • Quantification of circulating tumor cells using multiplexed Surface-Enhanced Raman Scattering Nanoparticles.
    Volume: 73
    04/15/2013 Authors: Wang X; Qian X; Beitler JJ; Chen ZG; Khuri FR; Lewis MM; Shin HJ; Nie S; Shin DM
  • p90RSK2 coordinates pro-apoptotic and anti-apoptotic signaling pathways to protect cancer cells from anoikis.
    Volume: 73
    04/15/2013 Authors: Jin L; Li D; Lee J; Alesi GN; Fan J; Kang H-B; Wang D; Fu H; Taunton J; Boggon TJ
  • Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer.
    Cancer Volume: 119 Page(s): 1503 - 1511
    04/15/2013 Authors: Owonikoko TK; Hossain MS; Bhimani C; Chen Z; Kim S; Ramalingam SS; Sun S-Y; Shin DM; Waller EK; Khuri FR
  • Subceliular translocation of beta-catenin and its relationship with EGFR activation in HPV16 positive OPSCC
    Volume: 73
    04/15/2013 Authors: Hu Z; Jiang N; Muller S; Saba N; Wang D; Zhang H; Shin DM; Chen ZG
  • Role of ribonucleotide reductase subunit M2 in regulation of head and neck and lung cancer undergoing invasion.
    Volume: 73
    04/15/2013 Authors: Rahman MA; Amin ARMR; Nannapaneni S; Hu Z; Kang H; Chen ZG; Shin DM
  • Prognostic impact of Fas-associated death domain, a key component in death receptor signaling, is dependent on the presence of lymph node metastasis in head and neck squamous cell carcinoma.
    Cancer Biol Ther Volume: 14 Page(s): 365 - 369
    04/01/2013 Authors: Fan S; Mller S; Chen ZG; Pan L; Tighiouart M; Shin DM; Khuri FR; Sun S-Y
  • A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies.
    Br J Cancer Volume: 108 Page(s): 762 - 765
    03/05/2013 Authors: Harvey RD; Owonikoko TK; Lewis CM; Akintayo A; Chen Z; Tighiouart M; Ramalingam SS; Fanucchi MP; Nadella P; Rogatko A
  • Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer.
    J Thorac Oncol Volume: 8 Page(s): 369 - 372
    03/01/2013 Authors: Ramalingam SS; Owonikoko TK; Behera M; Subramanian J; Saba NF; Kono SA; Gal AA; Sica G; Harvey RD; Chen Z
  • Laryngeal tumor volume as a predictor for thyroid cartilage penetration.
    Head Neck Volume: 35 Page(s): 426 - 430
    03/01/2013 Authors: Kats SS; Muller S; Aiken A; Hudgins PA; Wadsworth JT; Shin DM; Khuri F; Beitler JJ
  • Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies.
    Clin Cancer Res Volume: 19 Page(s): 1244 - 1256
    03/01/2013 Authors: Shin DM; Zhang H; Saba NF; Chen AY; Nannapaneni S; Amin ARMR; Mller S; Lewis M; Sica G; Kono S
  • Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck.
    Head Neck Volume: 35 Page(s): 443 - 453
    03/01/2013 Authors: Shin DM; Khuri FR
  • N-(phosphonacetyl)-L-aspartate induces TAp73-dependent apoptosis by modulating multiple Bcl-2 proteins: potential for cancer therapy.
    Oncogene Volume: 32 Page(s): 920 - 929
    02/14/2013 Authors: Ruhul Amin ARM; Thakur VS; Gupta K; Agarwal MK; Wald DN; Shin DM; Agarwal ML
  • Epidermal growth factor promotes protein degradation of epithelial protein lost in neoplasm (EPLIN), a putative metastasis suppressor, during epithelial-mesenchymal transition.
    J Biol Chem Volume: 288 Page(s): 1469 - 1479
    01/18/2013 Authors: Zhang S; Wang X; Iqbal S; Wang Y; Osunkoya AO; Chen Z; Chen Z; Shin DM; Yuan H; Wang YA
  • Clinical efficacy of targeted biologic agents as second-line therapy of advanced thyroid cancer.
    Oncologist Volume: 18 Page(s): 1262 - 1269
    01/01/2013 Authors: Owonikoko TK; Chowdry RP; Chen Z; Kim S; Saba NF; Shin DM; Khuri FR
  • Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation.
    Nat Commun Volume: 4 Page(s): 1790
    01/01/2013 Authors: Hitosugi T; Zhou L; Fan J; Elf S; Zhang L; Xie J; Wang Y; Gu T-L; Alekovi M; LeRoy G
  • Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer.
    PLoS One Volume: 8 Page(s): e74670
    01/01/2013 Authors: Li R; You S; Hu Z; Chen ZG; Sica GL; Khuri FR; Curran WJ; Shin DM; Deng X
  • Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.
    Cancer Cell Volume: 22 Page(s): 585 - 600
    11/13/2012 Authors: Hitosugi T; Zhou L; Elf S; Fan J; Kang H-B; Seo JH; Shan C; Dai Q; Zhang L; Xie J
  • Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 study.
    Cancer Volume: 118 Page(s): 4694 - 4705
    10/01/2012 Authors: Urba S; van Herpen CML; Sahoo TP; Shin DM; Licitra L; Mezei K; Reuter C; Hitt R; Russo F; Chang S-C
  • Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data.
    Cancer Volume: 118 Page(s): 4444 - 4451
    09/15/2012 Authors: Ellington CL; Goodman M; Kono SA; Grist W; Wadsworth T; Chen AY; Owonikoko T; Ramalingam S; Shin DM; Khuri FR
  • HPV positive squamous cell carcinoma of the oropharynx. Are we observing an unusual pattern of metastases?
    Head Neck Pathol Volume: 6 Page(s): 336 - 344
    09/01/2012 Authors: Mller S; Khuri FR; Kono SA; Beitler JJ; Shin DM; Saba NF
  • The pivotal role of integrin 1 in metastasis of head and neck squamous cell carcinoma.
    Clin Cancer Res Volume: 18 Page(s): 4589 - 4599
    09/01/2012 Authors: Wang D; Mller S; Amin ARMR; Huang D; Su L; Hu Z; Rahman MA; Nannapaneni S; Koenig L; Chen Z
  • A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment.
    Int J Cancer Volume: 131 Page(s): 956 - 969
    08/15/2012 Authors: Zhang H; Yun S; Batuwangala TD; Steward M; Holmes SD; Pan L; Tighiouart M; Shin HJC; Koenig L; Park W
  • Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.
    Eur J Cancer Volume: 48 Page(s): 1682 - 1691
    07/01/2012 Authors: Xu J; Mller S; Nannapaneni S; Pan L; Wang Y; Peng X; Wang D; Tighiouart M; Chen Z; Saba NF
  • Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts.
    Integr Biol (Camb) Volume: 4 Page(s): 633 - 640
    06/01/2012 Authors: Zhu S; Moore TW; Lin X; Morii N; Mancini A; Howard RB; Culver D; Arrendale RF; Reddy P; Evers TJ
  • Acetylated tubulin and risk of nodal metastases in squamous cell carcinoma of the head and neck (SCCHN)
    Volume: 30
    05/20/2012 Authors: Saba NF; Magliocca KR; Kim S; Muller S; Chen Z; Eggers C; Phelan VH; Kono SA; Owonikoko TK; Ramalingam SS
  • A phase I and pharmacokinetic study of multiple schedules of ganetespib (STA-9090), a heat shock protein 90 inhibitor, in combination with docetaxel for subjects with advanced solid tumor malignancies
    Volume: 30
    05/20/2012 Authors: Kauh JS; Harvey RD; Owonikoko TK; El-Rayes BF; Shin DM; Murali S; Lewis CM; Karol MD; Teofilovici F; Du Y
  • A phase I study of the safety and pharmacodynamic effects of everolimus in combination with lenalidomide in patients with advanced solid malignancies.
    Volume: 30
    05/20/2012 Authors: Owonikoko TK; Harvey RD; Kauh JS; Lewis CM; Hossain MS; Akintayo AO; Merriewether AR; Chen Z; Hawk NN; Saba NF
  • Paranasal sinus squamous cell carcinomas (PNSSCC) incidence and survival trends.
    Volume: 30
    05/20/2012 Authors: Ansa B; Goodman M; Ward K; Kono SA; Kunle T; Grist OW; Wadsworth T; El-Deiry M; Chen AY; Ramalingam SS
  • Behavior of circulating tumor cells detected by EGF tagged SERS nanoparticles in head and neck cancer patients
    Volume: 30
    05/20/2012 Authors: Beitler JJ; Wang X; Qian X; Wang H; Chen ZG; Khuri FR; Nie S; Shin DM
  • Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth.
    J Control Release Volume: 159 Page(s): 384 - 392
    05/10/2012 Authors: Rahman MA; Amin ARMR; Wang X; Zuckerman JE; Choi CHJ; Zhou B; Wang D; Nannapaneni S; Koenig L; Chen Z
  • Prognostic significance of nuclear factor kappa B expression in human papillomavirus-associated oropharyngeal cancer
    CANCER RESEARCH Volume: 72
    04/15/2012 Authors: Zhang H; Hu Z; Phelan V; Liu Y; Muller S; Saba NF; Beitler JJ; Khuri FR; Chen GZ; Shin DM
  • Proteomic study using a newly established metastatic lung cancer model
    CANCER RESEARCH Volume: 72
    04/15/2012 Authors: Wang D; Hu Z; Koenig L; Nannapaneni S; Shin DM; Chen ZG
  • RSK2 mediates anti-anoikis signals by regulating downstream factors through both transcription -independent and -dependent manner in human cancers
    CANCER RESEARCH Volume: 72
    04/15/2012 Authors: Lee JS; Jin L; Li D; Kim LS; Taunton J; Chen GZ; Shin DM; Kang S
  • Overcoming DDP resistance using folic acid-heparin-DDP nanoparticles
    CANCER RESEARCH Volume: 72
    04/15/2012 Authors: Peng X; Wang Y; Chen ZG; Nie S; Shin DM
  • Ribonucleotide reductase subunit M2 regulates Bcl-2 in human cancer: A potential target for cancer therapy
    CANCER RESEARCH Volume: 72
    04/15/2012 Authors: Rahman MA; Amin ARMR; Koenig L; Nannapaneni S; Chen ZG; Shin DM
  • Honokiol reduces drug resistance by down-regulation of survivin expression in multidrug resistant squamous cell carcinoma of the head and neck
    CANCER RESEARCH Volume: 72
    04/15/2012 Authors: Wang X; Beitler JJ; Hong HW; Lee MJ; Chen Z; Koenig L; Amin ARR; Chen ZG; Arbiser JL; Shin DM
  • Synergistic apoptosis by combination of natural compound EGCG and resveratrol in head and neck cancer: Potential role for AKT-dependent signaling
    CANCER RESEARCH Volume: 72
    04/15/2012 Authors: Amin ARMR; Rahman MA; Wang D; Khuri FR; Chen ZG; Shin DM
  • Pharmacodynamics of DT-IgG, a dual-targeting antibody against VEGF-EGFR, in tumor xenografted mice.
    Cancer Chemother Pharmacol Volume: 69 Page(s): 577 - 590
    03/01/2012 Authors: Hurwitz SJ; Zhang H; Yun S; Batuwangala TD; Steward M; Holmes SD; Rycroft D; Pan L; Tighiouart M; Shin HJC
  • Human immunodeficiency virus-associated lung cancer in the era of highly active antiretroviral therapy.
    Cancer Volume: 118 Page(s): 164 - 172
    01/01/2012 Authors: Pakkala S; Chen Z; Rimland D; Owonikoko TK; Gunthel C; Brandes JR; Saba NR; Shin DM; Curran WJ; Khuri FR
  • Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles.
    ACS Nano Volume: 5 Page(s): 9480 - 9493
    12/27/2011 Authors: Peng X-H; Wang Y; Huang D; Wang Y; Shin HJ; Chen Z; Spewak MB; Mao H; Wang X; Wang Y
  • EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis.
    Oncogene Volume: 30 Page(s): 4941 - 4952
    12/15/2011 Authors: Zhang S; Wang X; Osunkoya AO; Iqbal S; Wang Y; Chen Z; Mller S; Chen Z; Josson S; Coleman IM
  • Patterns of extralaryngeal spread of laryngeal cancer: thyroid cartilage penetration occurs in a minority of patients with extralaryngeal spread of laryngeal squamous cell cancers.
    Cancer Volume: 117 Page(s): 5047 - 5051
    11/15/2011 Authors: Chen SA; Muller S; Chen AY; Hudgins PA; Shin DM; Khuri F; Saba NF; Beitler JJ
  • Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR.
    Mol Cancer Volume: 10 Page(s): 116
    09/22/2011 Authors: Wang D; Su L; Huang D; Zhang H; Shin DM; Chen ZG
  • Farnesyl transferase expression determines clinical response to the docetaxel-lonafarnib combination in patients with advanced malignancies.
    Cancer Volume: 117 Page(s): 4049 - 4059
    09/01/2011 Authors: Kauh J; Chanel-Vos C; Escuin D; Fanucchi MP; Harvey RD; Saba N; Shin DM; Gal A; Pan L; Kutner M
  • A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model.
    ACS Nano Volume: 5 Page(s): 6184 - 6194
    08/23/2011 Authors: Wang X; Li J; Wang Y; Koenig L; Gjyrezi A; Giannakakou P; Shin EH; Tighiouart M; Chen ZG; Nie S
  • Survival outcomes of nonoperative therapy (NOT) alone versus NOT followed by surgery (NOTS) in patients with esophageal cancer (EC): SEER analysis 2000-2007.
    JOURNAL OF CLINICAL ONCOLOGY Volume: 29
    05/20/2011 Authors: Saba NF; Kim HM; El-Rayes BF; Kono SA; Ramalingam SS; Owonikoko TK; Landry JC; Miller DL; Shin DM; Khuri FR
  • Comparison of native and adaptive immunity profiles of healthy volunteers and patients with well-differentiated thyroid cancer.
    JOURNAL OF CLINICAL ONCOLOGY Volume: 29
    05/20/2011 Authors: Hossain S; Bhimani C; Chen Z; Ramalingam SS; Shin DM; Cohen C; Khuri FR; Waller E; Owonikoko TK
  • Survival outcomes of nonoperative therapy (NOT) alone versus NOT followed by surgery (NOTS) in patients with esophageal cancer (EC): SEER analysis 2000-2007.
    J Clin Oncol Volume: 29 Page(s): e14569
    05/20/2011 Authors: Saba NF; Kim HM; El-Rayes BF; Kono SA; Ramalingam SS; Owonikoko TK; Landry JC; Miller DL; Shin DM; Khuri FR
  • Comparison of native and adaptive immunity profiles of healthy volunteers and patients with well-differentiated thyroid cancer.
    J Clin Oncol Volume: 29 Page(s): 5585
    05/20/2011 Authors: Hossain S; Bhimani C; Chen Z; Ramalingam SS; Shin DM; Cohen C; Khuri FR; Waller E; Owonikoko TK
  • Everolimus, an mTOR inhibitor, in combination with docetaxel for second- or third-line therapy of advanced-stage non-small cell lung cancer: A phase II study.
    J Clin Oncol Volume: 29 Page(s): e13601
    05/20/2011 Authors: Khuri FR; Owonikoko TK; Subramanian J; Sica G; Behera M; Saba NF; Chen Z; Tighiouart M; Shin DM; Sun S
  • Detecting multiplexed biomarkers for predicting lymph node metastasis by using quantum dots technology
    Volume: 71
    04/15/2011 Authors: Xu J; Huang D; Wang Y; Hoyt CC; Peng X; Wang D; Zhang H; Shin DM; Chen ZG
  • Potent curcumin analogue FLLL-22, but not natural curcumin, targets the DNA damage pathway for apoptosis in lung and head and neck cancer cells
    CANCER RESEARCH Volume: 71
    04/15/2011 Authors: Amin ARMR; Lee M; Rahman MA; Fuchs JR; Chen ZG; Shin DM
  • Targeting cell survival pathways with the combination of honokiol and resveratrol for prevention of head and neck cancer
    CANCER RESEARCH Volume: 71
    04/15/2011 Authors: Amin ARMR; Jung K-H; Wang D; Arbiser JL; Chen ZG; Shin DM
  • Ribonucleotide reductase subunit M2 promotes cell invasiveness and motility in lung and head and neck cancer cells
    CANCER RESEARCH Volume: 71
    04/15/2011 Authors: Rahman MA; Amin ARMR; Chen ZG; Davis ME; Shin DM
  • Profiling counter-regulatory and cytotoxic immune pathways with cellular biomarkers in thyroid cancer patients
    CANCER RESEARCH Volume: 71
    04/15/2011 Authors: Hossain MS; Bhimani C; Chen Z; Shin D; Ramalingam SS; Khuri FR; Edmund WK; Owonikoko TK
  • Profiling counter-regulatory and cytotoxic immune pathways with cellular biomarkers in thyroid cancer patients
    CANCER RESEARCH Volume: 71
    04/15/2011 Authors: Hossain MS; Bhimani C; Chen Z; Shin D; Ramalingam SS; Khuri FR; Edmund WK; Owonikoko TK
  • Mislocalization of ATBF1 is associated with progression of head and neck squamous cell carcinoma
    CANCER RESEARCH Volume: 71
    04/15/2011 Authors: Sun X; Li J; Sica G; Fan S-Q; Wang Y; Chen Z; Muller S; Chen ZG; Shin DM; Dong J-T
  • Targeted therapy of lung cancer using ScFvEGFR-Heparin-Cisplatin nanoparticles
    CANCER RESEARCH Volume: 71
    04/15/2011 Authors: Peng X; Wang Y; Wang Y; Huang D; Chen ZG; Nie S; Shin DM
  • RSK2 phosphorylates and activates CREB to promote HNSCC cell invasion through upregulation of pro-metastatic MCAM and Fascin-1
    CANCER RESEARCH Volume: 71
    04/15/2011 Authors: Jin L; Kim Y-M; Zhou W; Taunton J; Chen GZ; Shin DM; Khuri FR; Kang S
  • A folate receptor-targeted nanoparticle minimizes multidrug resistance in human cancer xenograft model
    CANCER RESEARCH Volume: 71
    04/15/2011 Authors: Wang X; Li J; Wang Y; Koenig L; Gjyrezi A; Giannakakou P; Shin EH; Tighiouart M; Chen Z; Nie S
  • Study of 2, 9-disecbutyl-1, 10-phenanthroline as a novel anticancer agent
    CANCER RESEARCH Volume: 71
    04/15/2011 Authors: Wang D; Amin ARMR; Peng S; Sanghvi C; Shin DM; Eichler JF
  • Inhibition of head and neck squamous cell carcinoma growth by combination treatment of erlotinib and celecoxib: Potential chemopreventive agents
    CANCER RESEARCH Volume: 71
    04/15/2011 Authors: Zhang H; Nannapaneni S; Chen Z; Saba N; Khuri FR; Chen GZ; Shin DM
  • Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles.
    Cancer Res Volume: 71 Page(s): 1526 - 1532
    03/01/2011 Authors: Wang X; Qian X; Beitler JJ; Chen ZG; Khuri FR; Lewis MM; Shin HJC; Nie S; Shin DM
  • Application of nanoparticle quantum dot as a unique tool for identification of high risk cancer cells for metastasis
    CLINICAL & EXPERIMENTAL METASTASIS Volume: 28 Page(s): 191 - 191
    02/01/2011 Authors: Xu J; Huang D; Wang Y; Hoyt CC; Peng X; Wang D; Zhang H; Shin DM; Chen ZG
  • Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results program-based analysis.
    Oncology Volume: 81 Page(s): 12 - 20
    01/01/2011 Authors: Saba NF; Goodman M; Ward K; Flowers C; Ramalingam S; Owonikoko T; Chen A; Grist W; Wadsworth T; Beitler JJ
  • Targeted Magnetic Iron Oxide Nanoparticles for Tumor Imaging and Therapy
    Page(s): 203 - 224
    01/01/2011 Authors: Peng X; Chen H; Huang J; Mao H; Shin DM
  • Detection and treatment of metastatic cancers using nanotechnology
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE Volume: 28 Page(s): S51 - S51
    01/01/2011 Authors: Chen GZ; Huang D; Wang X; Xu J; Li J; Muller S; Thighiouart M; Nie S; Shin DM
  • c-Jun NH2-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAIL.
    Mol Cancer Volume: 9 Page(s): 315
    12/20/2010 Authors: Fu L; Lin Y-D; Elrod HA; Yue P; Oh Y; Li B; Tao H; Chen GZ; Shin DM; Khuri FR
  • Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53.
    J Biol Chem Volume: 285 Page(s): 34557 - 34565
    11/05/2010 Authors: Amin ARMR; Wang D; Zhang H; Peng S; Shin HJC; Brandes JC; Tighiouart M; Khuri FR; Chen ZG; Shin DM
  • Thymic Neoplasms
    CURRENT PROBLEMS IN CANCER Volume: 34 Page(s): 328 - 366
    11/01/2010 Authors: Forquer JA
  • A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands.
    ACS Nano Volume: 4 Page(s): 5887 - 5896
    10/26/2010 Authors: Huang X; Peng X; Wang Y; Wang Y; Shin DM; El-Sayed MA; Nie S
  • PHASE III STUDY OF PEMETREXED IN COMBINATION WITH CISPLATIN (PEM/CIS) VERSUS PLACEBO PLUS CISPLATIN (CIS) IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS CELL HEAD AND NECK CANCER (HNC)
    Volume: 21 Page(s): 314 - 314
    10/01/2010 Authors: Urba S; van Herpen CM; Sahoo TP; Shin DM; Licitra L; Mezei K; Reuter C; Hossain AM; Chang S; Hong R
  • caGrid-Enabled caBIG Silver Level Compatible Head and Neck Cancer Tissue Database System.
    Open Med Inform J Volume: 4 Page(s): 171 - 178
    09/01/2010 Authors: Wang H; Bouzyk E; Kuehn A; Muller S; Chen Z; Khuri FR; Shin DM; Rogatko A; Tighiouart M
  • Analysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impact.
    PLoS One Volume: 5 Page(s): e12178
    08/16/2010 Authors: Elrod HA; Fan S; Muller S; Chen GZ; Pan L; Tighiouart M; Shin DM; Khuri FR; Sun S-Y
  • Phase 1 and pharmacokinetic study of everolimus, a mammalian target of rapamycin inhibitor, in combination with docetaxel for recurrent/refractory nonsmall cell lung cancer.
    Cancer Volume: 116 Page(s): 3903 - 3909
    08/15/2010 Authors: Ramalingam SS; Harvey RD; Saba N; Owonikoko TK; Kauh J; Shin DM; Sun S-Y; Strychor S; Tighiouart M; Egorin MJ
  • Chemoprevention of head and neck cancer with green tea polyphenols.
    Cancer Prev Res (Phila) Volume: 3 Page(s): 900 - 909
    08/01/2010 Authors: Kim JW; Amin ARMR; Shin DM
  • Application of Nanotechnology in Cancer Therapy and Imaging
    Volume: 42 Page(s): 13 - 13
    08/01/2010 Authors: Shin DM
  • Cancer prevention with natural compounds.
    Semin Oncol Volume: 37 Page(s): 258 - 281
    06/01/2010 Authors: Gullett NP; Ruhul Amin ARM; Bayraktar S; Pezzuto JM; Shin DM; Khuri FR; Aggarwal BB; Surh Y-J; Kucuk O
  • Combination therapy with sunitinib and bortezomib in adult patients with radioiodine refractory thyroid cancer
    JOURNAL OF CLINICAL ONCOLOGY Volume: 28
    05/20/2010 Authors: Harvey RD; Kauh JS; Ramalingam SS; Lewis CM; Chen Z; Lonial S; Blount IC; Shin DM; Khuri FR; Owanikoko TK
  • Phase IB dose escalation study of bortezomib and sunitinib in patients with refractory solid tumors.
    JOURNAL OF CLINICAL ONCOLOGY Volume: 28
    05/20/2010 Authors: Kauh JS; Harvey RD; Lawson DH; Owonikoko TK; Tighiouart M; Ramalingam SS; Shin DM; Lewis CM; El-Rayes BF; Khuri FR
  • Survival impact of newly approved therapeutic agents in patients with advanced non-small cell lung cancer (NSCLC): A SEER-Medicare database analysis.
    JOURNAL OF CLINICAL ONCOLOGY Volume: 28
    05/20/2010 Authors: Owonikoko TK; Ramalingam SS; Behera M; Brandes JC; Saba NF; Bhimani C; Harichand-Herdt S; Shin DM; Khuri FR; Ragin C
  • Evaluation of ALDH1-A1 as a biomarker for metastasis of head and neck cancer
    JOURNAL OF CLINICAL ONCOLOGY Volume: 28
    05/20/2010 Authors: Chen ZG; Nannapaneni S; Muller S; Saba NF; Tighiouart M; Pan L; Shin DM
  • Chemoprevention with erlotinib and celecoxib in advanced premalignant lesions of the head and neck: Results of a phase I study
    JOURNAL OF CLINICAL ONCOLOGY Volume: 28
    05/20/2010 Authors: Saba NF; Muller S; Chen AY; Grist W; Gibson K; Nannapaneni S; Yang CS; Khuri FR; Chen ZG; Shin DM
  • Prognostic accuracy of computed tomography findings for patients with laryngeal cancer undergoing laryngectomy.
    J Clin Oncol Volume: 28 Page(s): 2318 - 2322
    05/10/2010 Authors: Beitler JJ; Muller S; Grist WJ; Corey A; Klein AM; Johns MM; Perkins CL; Davis LW; Udayasanker U; Landry JC
  • Targeted delivery of paclitaxel to tumor cells: synthesis and in vitro evaluation.
    J Med Chem Volume: 53 Page(s): 3127 - 3132
    04/22/2010 Authors: Ndungu JM; Lu YJ; Zhu S; Yang C; Wang X; Chen G; Shin DM; Snyder JP; Shoji M; Sun A
  • p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells.
    J Clin Invest Volume: 120 Page(s): 1165 - 1177
    04/01/2010 Authors: Kang S; Elf S; Lythgoe K; Hitosugi T; Taunton J; Zhou W; Xiong L; Wang D; Muller S; Fan S
  • Quantification of circulating tumor cells in peripheral blood using EGFR-targeting gold nanoparticles
    CANCER RESEARCH Volume: 70
    04/01/2010 Authors: Wang X; Qian X; Beitler JJ; Chen ZG; Nie S; Shin DM
  • Nanoparticle mediated delivery of siRNA targeting RRM2 inhibits tumor growth of head and neck and lung cancers
    Volume: 70
    04/01/2010 Authors: Rahman MA; Amin ARMR; Wang X; Wang D; Davis ME; Zhou B; Yen Y; Chen ZG; Shin DM
  • Cytoplasmic location of CXCR4 is correlated to loss of EMT marker and activation of downstream signaling pathway in non-small cell lung cancer
    Volume: 70
    04/01/2010 Authors: Wang Y; Huang D; Fu H; Wang D; Koenig L; Khuri FR; Shin DM; Chen ZG
  • Analysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impact
    Volume: 70
    04/01/2010 Authors: Elrod HA; Fan S; Muller S; Chen GZ; Pan L; Tighiouart M; Shin DM; Khuri FR; Sun S-Y
  • Acetylated tubulin (AT) levels predicts response to TPF chemotherapy in locally advanced head and neck squamous cell carcinoma (HNSCC)
    CANCER RESEARCH Volume: 70
    04/01/2010 Authors: Saba NF; Marcus A; Beitler JJ; Muller S; Eggers C; Grist W; Chen A; Chen Z; Shin DM; Khuri FR
  • RED GINSENG EXTRACTS IMPROVED CORONARY FLOW RESERVE AND INCREASED ABSOLUTE NUMBERS OF VARIOUS CIRCULATING ANGIOGENIC CELLS IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION
    Volume: 55
    03/09/2010 Authors: Shin D; Hong SJ; Choi JH; Kim JH; Kim JS; Park JH; Ahn C-M; Lim D-S
  • Restoration of p53 functions protects cells from concanavalin A-induced apoptosis.
    Mol Cancer Ther Volume: 9 Page(s): 471 - 479
    02/01/2010 Authors: Amin ARMR; Thakur VS; Gupta K; Jackson MW; Harada H; Agarwal MK; Shin DM; Wald DN; Agarwal ML
  • The medicinal chemistry of theragnostics, multimodality imaging and applications of nanotechnology in cancer.
    Curr Top Med Chem Volume: 10 Page(s): 1211 - 1226
    01/01/2010 Authors: Majumdar D; Peng X-H; Shin DM
  • Laryngeal Tumor Volume as a Predictor for Thyroid Cartilage Penetration
    Volume: 78 Page(s): S432 - S433
    01/01/2010 Authors: Kats SS; Hudgins PA; Wadsworth JT; Shin DM; Beitler JJ
  • Seventy-five Percent of Extralaryngeal Larynx Cancers Respect the Thyroid Cartilage: A Modern Clinicopathologic Review of 89 Total Laryngectomy Specimens Show New Patterns of Spread
    Volume: 78 Page(s): S176 - S177
    01/01/2010 Authors: Beitler JJ; Chen SA; Shin DM; Chen AY; Muller S; Hudgins PA
  • Chemopreventive potential of natural compounds in head and neck cancer.
    Nutr Cancer Volume: 62 Page(s): 973 - 987
    01/01/2010 Authors: Rahman MA; Amin ARMR; Shin DM
  • Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: a retrospective single-institution analysis.
    Head Neck Volume: 31 Page(s): 1447 - 1455
    11/01/2009 Authors: Saba NF; Edelman S; Tighiouart M; Gaultney J; Davis LW; Khuri FR; Chen A; Grist W; Shin DM
  • Oral cancer prevention advances with a translational trial of green tea.
    Cancer Prev Res (Phila) Volume: 2 Page(s): 919 - 921
    11/01/2009 Authors: Shin DM
  • HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors.
    ACS Nano Volume: 3 Page(s): 3165 - 3174
    10/27/2009 Authors: Wang X; Li J; Wang Y; Cho KJ; Kim G; Gjyrezi A; Koenig L; Giannakakou P; Shin HJC; Tighiouart M
  • Sequence dependence of cell growth inhibition by EGFR-tyrosine kinase inhibitor ZD1839, docetaxel, and cisplatin in head and neck cancer.
    Head Neck Volume: 31 Page(s): 1263 - 1273
    10/01/2009 Authors: Klass CM; Choe MS; Hurwitz SJ; Tighiouart M; Zhang X; Chen ZG; Shin DM
  • Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma.
    Cancer Prev Res (Phila) Volume: 2 Page(s): 823 - 829
    09/01/2009 Authors: Saba NF; Choi M; Muller S; Shin HJC; Tighiouart M; Papadimitrakopoulou VA; El-Naggar AK; Khuri FR; Chen ZG; Shin DM
  • A phase I study of everolimus, an mTOR inhibitor, in combination with docetaxel for recurrent/refractory non-small cell lung cancer
    JOURNAL OF THORACIC ONCOLOGY Volume: 4 Page(s): S594 - S595
    09/01/2009 Authors: Owonikoko TK; Ramalingam SS; Harvey D; Saba NF; Kauh J; Shin DM; Sun S-Y; Browning K; Tighiouart M; Khuri FR
  • Quantum dot-based quantification revealed differences in subcellular localization of EGFR and E-cadherin between EGFR-TKI sensitive and insensitive cancer cells.
    Nanotechnology Volume: 20 Page(s): 225102
    06/03/2009 Authors: Huang D-H; Su L; Peng X-H; Zhang H; Khuri FR; Shin DM; Chen ZG
  • Perspectives for cancer prevention with natural compounds.
    J Clin Oncol Volume: 27 Page(s): 2712 - 2725
    06/01/2009 Authors: Amin ARMR; Kucuk O; Khuri FR; Shin DM
  • Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB.
    Cancer Prev Res (Phila) Volume: 2 Page(s): 538 - 545
    06/01/2009 Authors: Amin ARMR; Khuri FR; Chen ZG; Shin DM
  • Everolimus, an mTOR inhibitor, in combination with docetaxel for recurrent/refractory NSCLC: A phase I study
    Volume: 27
    05/20/2009 Authors: Khuri FR; Harvey RD; Saba NF; Owonikoko TK; Kauh J; Shin DM; Sun SY; Browning KM; Tighiouart M; Ramalingam SS
  • Everolimus, an mTOR inhibitor, in combination with docetaxel for recurrent/refractory NSCLC: A phase I study.
    J Clin Oncol Volume: 27 Page(s): 8060
    05/20/2009 Authors: Khuri FR; Harvey RD; Saba NF; Owonikoko TK; Kauh J; Shin DM; Sun SY; Browning KM; Tighiouart M; Ramalingam SS
  • Possible pivotal roles of integrin \#946;1 in metastasis of head and neck squamous cell carcinoma
    Volume: 69
    05/01/2009 Authors: Wang D; Muller S; Huang D; Su L; Shin D; Chen Z
  • Development of a quantum dots (QDs)-based quantification method for multiplexed biomarkers in prediction of metastasis
    Volume: 69
    05/01/2009 Authors: Huang D-H; Hoyt C; Peng X-H; Wang D; Zhang H; Khuri F; Shin D; Chen Z
  • In vitro and in vivo synergistic anti-tumor efficacy of two naturally available dietary polyphenols EGCG and luteolin
    Volume: 69
    05/01/2009 Authors: Amin A; Wang D; Khuri F; Chen Z; Shin D
  • Biodistribution of cisplatinloaded magnetic iron oxide nanoparticles in nude mice bearing human head and neck cancer
    CANCER RESEARCH Volume: 69
    05/01/2009 Authors: Peng X; Wang Y; Huang D-H; Mao H; Wang Y; Chen Z; Nie S; Shin D
  • A novel folate receptor-targeted nanoparticle minimizes drug resistance in a human cancer model
    CANCER RESEARCH Volume: 69
    05/01/2009 Authors: Wang X; Wang Y; Li J; Nannapaneni S; Tighiouart M; Chen ZG; Nie S; Shin D
  • Anticancer activity profiling of a panel of curcumin analogues in head and neck and lung cancer cells
    CANCER RESEARCH Volume: 69
    05/01/2009 Authors: Iou B; Du Y; Kasinski A; Thomas S; Sun A; Sun S-Y; Chen G; Shin D; Khuri F; Liotta D
  • In vitro and in vivo synergistic anti-tumor efficacy of two naturally available dietary polyphenols EGCG and luteolin
    CANCER RESEARCH Volume: 69
    05/01/2009 Authors: Amin A; Wang D; Khuri F; Chen Z; Shin D
  • A novel antiangiogenic feature of a dual targeting antibody (DMS3008) against EGFR and VEGF
    Volume: 69
    05/01/2009 Authors: Zhang H; Yun S; Batuwangala T; Steward M; Pan L; Tighiouart M; Chen ZG; Shin DM
  • Synergistic growth inhibition of squamous cell carcinoma of the head and neck by Erlotinib and EGCG: the role of p53-dependent inhibition of nuclear factor-\#922;B
    Volume: 69
    05/01/2009 Authors: Amin ARM; Zhang X; Khuri F; Chen Z; Shin D
  • Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation.
    Ann Oncol Volume: 20 Page(s): 921 - 927
    05/01/2009 Authors: Posner MR; Norris CM; Wirth LJ; Shin DM; Cullen KJ; Winquist EW; Blajman CR; Mickiewicz EA; Frenette GP; Plinar LF
  • Anticancer activity profiling of a panel of curcumin analogues in head and neck and lung cancer cells
    CANCER RESEARCH Volume: 69
    05/01/2009 Authors: Lou B; Du Y; Kasinski A; Thomas S; Sun A; Sun S-Y; Chen G; Shin D; Khuri F; Liotta D
  • Web-based head and neck cancer tissue database
    Volume: 69
    05/01/2009 Authors: Wang H; Kuehn A; Bouzyk E; Muller S; Khuri F; Shin D; Tighiouart M
  • Label-free biosensor technology for monitoring oncogenic signaling pathways
    CANCER RESEARCH Volume: 69
    05/01/2009 Authors: Du Y; Zhao J; Chen ZG; Shin DM; Khui FR; Fu H
  • Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer.
    J Clin Oncol Volume: 27 Page(s): 1976 - 1982
    04/20/2009 Authors: Holsinger FC; Kies MS; Diaz EM; Gillenwater AM; Lewin JS; Ginsberg LE; Glisson BS; Garden AS; Ark N; Lin HY
  • Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug.
    Head Neck Volume: 31 Page(s): 475 - 481
    04/01/2009 Authors: Saba NF; Wang X; Mller S; Tighiouart M; Cho K; Nie S; Chen Z; Shin DM
  • Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanisms.
    J Clin Oncol Volume: 27 Page(s): 1235 - 1242
    03/10/2009 Authors: Lai SY; Koppikar P; Thomas SM; Childs EE; Egloff AM; Seethala RR; Branstetter BF; Gooding WE; Muthukrishnan A; Mountz JM
  • Advances of cancer therapy by nanotechnology.
    Cancer Res Treat Volume: 41 Page(s): 1 - 11
    03/01/2009 Authors: Wang X; Wang Y; Chen ZG; Shin DM
  • Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy.
    J Clin Oncol Volume: 27 Page(s): 599 - 604
    02/01/2009 Authors: Papadimitrakopoulou VA; Lee JJ; William WN; Martin JW; Thomas M; Kim ES; Khuri FR; Shin DM; Feng L; Hong WK
  • Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors.
    Am J Clin Oncol Volume: 32 Page(s): 15 - 19
    02/01/2009 Authors: William WN; Lee JL; Shin DM; Hong WK; Liu S; Lee JJ; Lippman SM; Khuri FR; Kim ES
  • E3303: A Phase II Study of Cetuximab (C225) in Combination with Cisplatin (DDP) and Definitive Radiation (XRT) in Unresectable Squamous Cell Carcinoma of the Head and Neck (U-SCCHN)
    Volume: 75 Page(s): S15 - S15
    01/01/2009 Authors: Quon H; Langer CJ; Lee J; Patel UA; Shin DM; Argiris A; Ridge JA; Forastiere AA
  • Increased ALDH1 Expression in Squamous Cell Carcinoma of the Head and Neck May Be a Predictor for Lymph Node Metastases
    Volume: 89 Page(s): 250A - 250A
    01/01/2009 Authors: Muller S; Chen ZG; Nannapaneni S; Shin DM
  • WHOLE CELL IMPEDANCE ANALYSIS OF METASTATIC AND NON-METASTATIC CANCER CELLS
    Page(s): 399 - 402
    01/01/2009 Authors: Kim HS; Cho YH; Frazier AB; Chen ZG; Shin DM; Han A
  • Increased ALDH1 Expression in Squamous Cell Carcinoma of the Head and Neck May Be a Predictor for Lymph Node Metastases
    Volume: 22 Page(s): 250A - 250A
    01/01/2009 Authors: Muller S; Chen ZG; Nannapaneni S; Shin DM
  • Distinct growth factor-induced dynamic mass redistribution (DMR) profiles for monitoring oncogenic signaling pathways in various cancer cells.
    J Recept Signal Transduct Res Volume: 29 Page(s): 182 - 194
    01/01/2009 Authors: Du Y; Li Z; Li L; Chen ZG; Sun S-Y; Chen P; Shin DM; Khuri FR; Fu H
  • Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma.
    Br J Cancer Volume: 99 Page(s): 1684 - 1694
    11/18/2008 Authors: Zhang H; Su L; Mller S; Tighiouart M; Xu Z; Zhang X; Shin HJC; Hunt J; Sun S-Y; Shin DM
  • Effective combination of green tea EGCG and EGFR-TKI erlotinib for chemoprevention and therapy in head and neck cancer
    Volume: 6 Page(s): 38 - 38
    10/01/2008 Authors: Shin DM; Amin ARM; Zhang X; Chen ZG; Khuri FR
  • Recent advances in head and neck cancer.
    N Engl J Med Volume: 359 Page(s): 1143 - 1154
    09/11/2008 Authors: Haddad RI; Shin DM
  • Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor.
    Int J Cancer Volume: 123 Page(s): 1005 - 1014
    09/01/2008 Authors: Zhang X; Zhang H; Tighiouart M; Lee JE; Shin HJ; Khuri FR; Yang CS; Chen Z'G'; Shin DM
  • Nanoparticle therapeutics: an emerging treatment modality for cancer.
    Nat Rev Drug Discov Volume: 7 Page(s): 771 - 782
    09/01/2008 Authors: Davis ME; Chen ZG; Shin DM
  • Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Cancer Volume: 113 Page(s): 97 - 107
    07/01/2008 Authors: Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen ZG
  • Preliminary analysis of ECOG 3303: Concurrent radiation (RT), cisplatin (DDP) and cetuximab (C) in unresectable, locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN)
    JOURNAL OF CLINICAL ONCOLOGY Volume: 26
    05/20/2008 Authors: Langer CJ; Lee JW; Patel UA; Shin DM; Argiris AE; Quon H; Ridge JA; Forastiere AA
  • Research participants' views of nontherapeutic biopsies
    JOURNAL OF CLINICAL ONCOLOGY Volume: 26
    05/20/2008 Authors: Pentz RD; Xu Z; Lonial S; Kauh JS; O'Regan RM; Waller EK; Shin DM; Fu H; Khuri F
  • Defining the interaction of docetaxel and lonafarnib in patients with advanced malignancies
    Volume: 68
    05/01/2008 Authors: Kauh J; Fanucchi M; Escuin D; Saba N; Shin D; Gal A; Kutner M; Harvey D; Giannakakou P; Khuri F
  • Inhibition of Erlotinib-induced checkpoint but not apoptotic targets by EGCG: Implication for their anti-tumor synergism in squamous cell carcinoma of the head and neck
    Volume: 68
    05/01/2008 Authors: Amin ARM; Zhang X; Khuri F; Chen Z; Shin D
  • Concurrent platinum-based chemotherapy and simultaneous modulated accelerated radiation therapy for locally advanced squamous cell carcinoma of the tongue base.
    Head Neck Volume: 30 Page(s): 327 - 335
    03/01/2008 Authors: Lawson JD; Otto K; Chen A; Shin DM; Davis L; Johnstone PAS
  • Therapeutic nanoparticles for drug delivery in cancer.
    Clin Cancer Res Volume: 14 Page(s): 1310 - 1316
    03/01/2008 Authors: Cho K; Wang X; Nie S; Chen ZG; Shin DM
  • Head and neck cancer chemoprevention gets a shot in the arm.
    J Clin Oncol Volume: 26 Page(s): 345 - 347
    01/20/2008 Authors: Khuri FR; Shin DM
  • Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy.
    Int J Nanomedicine Volume: 3 Page(s): 311 - 321
    01/01/2008 Authors: Peng X-H; Qian X; Mao H; Wang AY; Chen ZG; Nie S; Shin DM
  • In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags.
    Nat Biotechnol Volume: 26 Page(s): 83 - 90
    01/01/2008 Authors: Qian X; Peng X-H; Ansari DO; Yin-Goen Q; Chen GZ; Shin DM; Yang L; Young AN; Wang MD; Nie S
  • Application of nanotechnology in cancer therapy and imaging.
    CA Cancer J Clin Volume: 58 Page(s): 97 - 110
    01/01/2008 Authors: Wang X; Yang L; Chen ZG; Shin DM
  • Targeting angiogenesis in head and neck cancer.
    Curr Cancer Drug Targets Volume: 7 Page(s): 643 - 649
    11/01/2007 Authors: Saba NF; Shin DM; Khuri FR
  • Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck.
    Cancer Res Volume: 67 Page(s): 10538 - 10545
    11/01/2007 Authors: Visus C; Ito D; Amoscato A; Maciejewska-Franczak M; Abdelsalem A; Dhir R; Shin DM; Donnenberg VS; Whiteside TL; DeLeo AB
  • Current status and future perspectives of chemoprevention in head and neck cancer.
    Curr Cancer Drug Targets Volume: 7 Page(s): 623 - 632
    11/01/2007 Authors: Klass CM; Shin DM
  • Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
    N Engl J Med Volume: 357 Page(s): 1705 - 1715
    10/25/2007 Authors: Posner MR; Hershock DM; Blajman CR; Mickiewicz E; Winquist E; Gorbounova V; Tjulandin S; Shin DM; Cullen K; Ervin TJ
  • CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models.
    Cancer Res Volume: 67 Page(s): 7518 - 7524
    08/01/2007 Authors: Yoon Y; Liang Z; Zhang X; Choe M; Zhu A; Cho HT; Shin DM; Goodman MM; Chen ZG; Shim H
  • Concurrent platinum-based chemotherapy with intensity modulated radiation therapy (IMRT) for locally advanced squamous cell carcinoma of the head and neck (SCCHN): A retrospective single institution analysis
    Volume: 25
    06/20/2007 Authors: Saba NF; Gaultney J; Edelman S; Tighiouart M; Davis LW; Khuri FR; Chen A; Grist W; Shin DM
  • Nanotechnology for targeted cancer therapy.
    Expert Rev Anticancer Ther Volume: 7 Page(s): 833 - 837
    06/01/2007 Authors: Wang MD; Shin DM; Simons JW; Nie S
  • Phase I clinical and pharmacodynamic evaluation of oral CI-1033 in patients with refractory cancer.
    Clin Cancer Res Volume: 13 Page(s): 3006 - 3014
    05/15/2007 Authors: Zinner RG; Nemunaitis J; Eiseman I; Shin HJC; Olson SC; Christensen J; Huang X; Lenehan PF; Donato NJ; Shin DM
  • Enhancement of docetaxel-induced cytotoxicity by blocking epidermal growth factor receptor and cyclooxygenase-2 pathways in squamous cell carcinoma of the head and neck.
    Clin Cancer Res Volume: 13 Page(s): 3015 - 3023
    05/15/2007 Authors: Choe MS; Chen Z; Klass CM; Zhang X; Shin DM
  • Induction of cell cycle arrest and apoptosis by a combined treatment with 13-cis-retinoic acid, interferon-alpha2a, and alpha-tocopherol in squamous cell carcinoma of the head and neck.
    Head Neck Volume: 29 Page(s): 351 - 361
    04/01/2007 Authors: Zhang X; Chen ZG; Khuri FR; Shin DM
  • Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer.
    Mol Cancer Ther Volume: 6 Page(s): 1414 - 1424
    04/01/2007 Authors: Zhang Q; Bhola NE; Lui VWY; Siwak DR; Thomas SM; Gubish CT; Siegfried JM; Mills GB; Shin D; Grandis JR
  • Down-regulation of S100A2 in lymph node metastases of head and neck cancer.
    Head Neck Volume: 29 Page(s): 236 - 243
    03/01/2007 Authors: Zhang X; Hunt JL; Shin DM; Chen ZG
  • Exploring cancer stem cell-like feature and potential treatment of metastatic SCCHN
    CLINICAL & EXPERIMENTAL METASTASIS Volume: 24 Page(s): 278 - 278
    01/01/2007 Authors: Chen ZG; Shin DM; Su L; Zhang X; Yoon Y; Liang Z; Zhang H; Shim H
  • Moving toward bioadjuvant approaches to head and neck cancer prevention.
    Volume: 69 Page(s): S132 - S135
    01/01/2007 Authors: Saba NF; Hammond A; Shin DM; Khuri FR
  • Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery.
    Mol Cancer Ther Volume: 5 Page(s): 1909 - 1917
    08/01/2006 Authors: Sinha R; Kim GJ; Nie S; Shin DM
  • Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.
    Clin Cancer Res Volume: 12 Page(s): 3661 - 3697
    06/15/2006 Authors: Kelloff GJ; Lippman SM; Dannenberg AJ; Sigman CC; Pearce HL; Reid BJ; Szabo E; Jordan VC; Spitz MR; Mills GB
  • Fenretinide activity in retinoid-resistant oral leukoplakia.
    Clin Cancer Res Volume: 12 Page(s): 3109 - 3114
    05/15/2006 Authors: Lippman SM; Lee JJ; Martin JW; El-Naggar AK; Xu X; Shin DM; Thomas M; Mao L; Fritsche HA; Zhou X
  • Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
    J Natl Cancer Inst Volume: 98 Page(s): 441 - 450
    04/05/2006 Authors: Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G
  • The role of caveolin-1 on lymph node metastasis of the head and neck cancer.
    Volume: 66
    04/01/2006 Authors: Zhang H; Ling S; Shin HJC; Muller S; Tighiouart M; Xu Z; Zhang X; Hunt J; Shin DM; Chen ZG
  • Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
    N Engl J Med Volume: 354 Page(s): 567 - 578
    02/09/2006 Authors: Bonner JA; Harari PM; Giralt J; Azarnia N; Shin DM; Cohen RB; Jones CU; Sur R; Raben D; Jassem J
  • Targeting the epidermal growth factor receptor. Trials in head and neck and lung cancer.
    Oncology (Williston Park) Volume: 20 Page(s): 153 - 161
    02/01/2006 Authors: Saba NF; Khuri FR; Shin DM
  • Understanding metastatic SCCHN cells from unique genotypes to phenotypes with the aid of an animal model and DNA microarray analysis.
    Clin Exp Metastasis Volume: 23 Page(s): 209 - 222
    01/01/2006 Authors: Zhang X; Su L; Pirani AA; Wu H; Zhang H; Shin DM; Gernert KM; Chen ZG
  • Correlation of cyclooxygenase-2 (COX-2) expression with tumor progression and survival in head and neck cancer (HNC)
    Volume: 14 Page(s): 2689S - 2689S
    11/01/2005 Authors: Klass C; Choe MS; Tighiouart M; Shin HJ; Rogatko A; Muller S; Papadimitrakopoulou VA; Khuri FR; Hong WK; Chen GZ
  • A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma.
    Int J Radiat Oncol Biol Phys Volume: 63 Page(s): 717 - 724
    11/01/2005 Authors: Johnson FM; Garden AS; Palmer JL; Shin DM; Morrison W; Papadimitrakopoulou V; Khuri F; Clayman G; Goepfert H; Ang KK
  • DNA microarray analysis in comparison of metastatic SCCHN with non-metastatic SCCHN reveals a feature of epithelial-mesenchymal transition
    Volume: 14 Page(s): 2690S - 2690S
    11/01/2005 Authors: Chen ZG; Wu HY; Zhang X; Su L; Pirani AA; Gernert KM; Shin DM
  • Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model.
    Clin Cancer Res Volume: 11 Page(s): 6261 - 6269
    09/01/2005 Authors: Zhang X; Chen ZG; Choe MS; Lin Y; Sun S-Y; Wieand HS; Shin HJC; Chen A; Khuri FR; Shin DM
  • Interaction between epidermal growth factor receptor- and cyclooxygenase 2-mediated pathways and its implications for the chemoprevention of head and neck cancer.
    Mol Cancer Ther Volume: 4 Page(s): 1448 - 1455
    09/01/2005 Authors: Choe MS; Zhang X; Shin HJC; Shin DM; Chen ZG
  • Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: a case series.
    Head Neck Volume: 27 Page(s): 748 - 756
    09/01/2005 Authors: Sturgis EM; Moore BA; Glisson BS; Kies MS; Shin DM; Byers RM
  • Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck.
    J Clin Oncol Volume: 23 Page(s): 5578 - 5587
    08/20/2005 Authors: Herbst RS; Arquette M; Shin DM; Dicke K; Vokes EE; Azarnia N; Hong WK; Kies MS
  • GRIM-19 expression and its correlation with clinical outcomes of an induction chemotherapy for patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    J Clin Oncol Volume: 23 Page(s): 5519
    06/01/2005 Authors: Zhang X; Choe MS; Lee JE; Muller S; Tighiouart M; Rogatko A; Glisson BS; Chen Z; Khuri FR; Shin DM
  • GRIM-19 expression and its correlation with clinical outcomes of an induction chemotherapy for patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Volume: 23 Page(s): 504S - 504S
    06/01/2005 Authors: Zhang X; Choe MS; Lee JE; Muller S; Tighiouart M; Rogatko A; Glisson BS; Chen Z; Khuri FR; Shin DM
  • Role of cyclooxygenase-2 (COX-2) expression in tumor progression and survival in the squamous cell carcinoma of the head and neck (HNSCC).
    Volume: 23 Page(s): 502S - 502S
    06/01/2005 Authors: Choe MS; Tighiouart M; Rogatko A; Muller S; Shin HJ; Francisco M; Papadimitrakopoulou VA; Khuri FR; Hong WK; Chen Z
  • Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma.
    J Clin Oncol Volume: 23 Page(s): 3495 - 3501
    05/20/2005 Authors: Lu C; Perez-Soler R; Piperdi B; Walsh GL; Swisher SG; Smythe WR; Shin HJ; Ro JY; Feng L; Truong M
  • Phase 1 clinical and pharmacokinetics evaluation of oral CI-1033 in patients with refractory cancer.
    Clin Cancer Res Volume: 11 Page(s): 3846 - 3853
    05/15/2005 Authors: Nemunaitis J; Eiseman I; Cunningham C; Senzer N; Williams A; Lenehan PF; Olson SC; Bycott P; Schlicht M; Zentgraff R
  • Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies.
    Cancer Chemother Pharmacol Volume: 55 Page(s): 354 - 360
    04/01/2005 Authors: Ramanathan RK; Ramalingam S; Egorin MJ; Belani CP; Potter DM; Fakih M; Jung LL; Strychor S; Jacobs SA; Friedland DM
  • Phase 2 bioadjuvant study of interferon alfa-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-up.
    Arch Otolaryngol Head Neck Surg Volume: 131 Page(s): 304 - 307
    04/01/2005 Authors: Seixas-Silva JA; Richards T; Khuri FR; Wieand HS; Kim E; Murphy B; Francisco M; Hong WK; Shin DM
  • The relationship of cetuximab-induced rash and survival in patients with head and neck cancer treated with radiotherapy and cetuximab
    Volume: 63 Page(s): S73 - S73
    01/01/2005 Authors: Bonner JA; Harari PM; Giralt J; Cohen R; Baselga J; Raben D; Shin DM; Ove R; Jassem J; Amellal N
  • Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis.
    Clin Cancer Res Volume: 10 Page(s): 8451 - 8459
    12/15/2004 Authors: Zhang X; Hunt JL; Landsittel DP; Muller S; Adler-Storthz K; Ferris RL; Shin DM; Chen ZG
  • Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck.
    Clin Cancer Res Volume: 10 Page(s): 5930 - 5939
    09/01/2004 Authors: Chen Z; Zhang X; Li M; Wang Z; Wieand HS; Grandis JR; Shin DM
  • Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report.
    Lung Cancer Volume: 44 Page(s): 369 - 379
    06/01/2004 Authors: Kim ES; Putnam JB; Komaki R; Walsh GL; Ro JY; Shin HJ; Truong M; Moon H; Swisher SG; Fossella FV
  • Phase I evaluation of docetaxel and topotecan for patients with advanced solid tumors.
    Cancer Volume: 100 Page(s): 2240 - 2245
    05/15/2004 Authors: Tsao AS; Shin DM; Palmer JL; Lee JS; Glisson BS
  • Phase I study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in solid tumors.
    Clin Cancer Res Volume: 10 Page(s): 2968 - 2976
    05/01/2004 Authors: Khuri FR; Glisson BS; Kim ES; Statkevich P; Thall PF; Meyers ML; Herbst RS; Munden RF; Tendler C; Zhu Y
  • Emerging drugs for head and neck cancer.
    Expert Opin Emerg Drugs Volume: 9 Page(s): 91 - 104
    05/01/2004 Authors: Rhee JC; Khuri FR; Shin DM
  • Prevention of head and neck cancer: current status and future prospects.
    Curr Probl Cancer Volume: 28 Page(s): 265 - 286
    01/01/2004 Authors: Jain S; Khuri FR; Shin DM
  • Advances in chemoprevention of head and neck cancer.
    Oncologist Volume: 9 Page(s): 302 - 311
    01/01/2004 Authors: Rhee JC; Khuri FR; Shin DM
  • Simultaneously targeting epidermal growth factor receptor (EGFR) and cycloxygenase-2 (COX-2) as a potential novel approach for chemoprevention of squamous cell carcinoma of the head and neck (SCCHN)
    Volume: 12 Page(s): 1318S - 1318S
    11/01/2003 Authors: Shin DM; Zhang X; Wang ZQ; Li MF; Grandis JR; Chen ZG
  • Expression of protease-activated receptor-1 (PAR-1): A differential marker for metastasis of squamous cell carcinoma of the head and neck (SCCHN)
    Volume: 12 Page(s): 1309S - 1309S
    11/01/2003 Authors: Zhang X; Hunt JL; Landsittel DP; Shin DM; Chen ZG
  • Detection of numerical aberrations of chromosomes 7 and 9 in cytologic specimens of pleural malignant mesothelioma.
    Cancer Volume: 99 Page(s): 233 - 239
    08/25/2003 Authors: Shin HJC; Shin DM; Tarco E; Sneige N
  • Advances in the management of malignant mesothelioma.
    Curr Oncol Rep Volume: 5 Page(s): 334 - 341
    07/01/2003 Authors: Khalil MY; Mapa M; Shin HJC; Shin DM
  • A phase I study of topotecan/paclitaxel alternating with etoposide/cisplatin and thoracic irradiation in patients with limited small cell lung cancer.
    Clin Cancer Res Volume: 9 Page(s): 2085 - 2091
    06/01/2003 Authors: Lu C; Komaki R; Lee JS; Shin DM; Palmer JL; Coldman BJ; Pisters KM; Kurie JM; Fossella FV; Glisson BS
  • Targeting epidermal growth factor receptor: novel therapeutics in the management of cancer.
    Expert Rev Anticancer Ther Volume: 3 Page(s): 367 - 380
    06/01/2003 Authors: Khalil MY; Grandis JR; Shin DM
  • Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma.
    J Clin Oncol Volume: 21 Page(s): 1556 - 1561
    04/15/2003 Authors: Scagliotti GV; Shin D-M; Kindler HL; Vasconcelles MJ; Keppler U; Manegold C; Burris H; Gatzemeier U; Blatter J; Symanowski JT
  • Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Cancer Volume: 97 Page(s): 1589
    03/15/2003 Authors: Haddad R; Posner M
  • Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck - Author reply
    CANCER Volume: 97 Page(s): 1590 - 1590
    03/15/2003 Authors: Shin DM
  • Prevention of radiation-induced oral cavity mucositis by plasmid/liposome delivery of the human manganese superoxide dismutase (SOD2) transgene.
    Radiat Res Volume: 159 Page(s): 361 - 370
    03/01/2003 Authors: Guo H; Seixas-Silva JA; Epperly MW; Gretton JE; Shin DM; Bar-Sagi D; Archer H; Greenberger JS
  • Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer.
    J Natl Cancer Inst Volume: 95 Page(s): 198 - 205
    02/05/2003 Authors: Izzo JG; Papadimitrakopoulou VA; Liu DD; den Hollander PLC; Babenko IM; Keck J; El-Naggar AK; Shin DM; Lee JJ; Hong WK
  • Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.
    Clin Cancer Res Volume: 9 Page(s): 93 - 101
    01/01/2003 Authors: Swisher SG; Roth JA; Komaki R; Gu J; Lee JJ; Hicks M; Ro JY; Hong WK; Merritt JA; Ahrar K
  • Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesions.
    Cancer Epidemiol Biomarkers Prev Volume: 11 Page(s): 1605 - 1610
    12/01/2002 Authors: Papadimitrakopoulou VA; Liu DD; Mao L; Shin DM; El-Naggar A; Ibarguen H; Lee JJ; Hong WK; Hittelman WN
  • Decrease in irradiation-induced oral cavity mucositis by plasmid/liposome delivery of the human manganese superoxide dismutase (MnSOD) transgene.
    Volume: 100 Page(s): 656A - 656A
    11/16/2002 Authors: Guo HL; Seixas-Silva JA; Epperly MW; Gretton JE; Shin DM; Bar-Sagi D; Archer H; Greenberger JS
  • Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Cancer Volume: 95 Page(s): 322 - 330
    07/15/2002 Authors: Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A
  • The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.
    Volume: 95 Page(s): 340 - 353
    07/15/2002 Authors: Herbst RS; Khuri FR; Lu C; Liu DD; Fossella FV; Glisson BS; Pisters KMW; Shin DM; Papadimitrakopoulou VA; Kurie JM
  • Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy.
    Cancer Volume: 94 Page(s): 1593 - 1611
    03/01/2002 Authors: Herbst RS; Shin DM
  • Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer.
    J Clin Oncol Volume: 20 Page(s): 364 - 370
    01/15/2002 Authors: Shin DM; Glisson BS; Khuri FR; Clifford JL; Clayman G; Benner SE; Forastiere AA; Ginsberg L; Liu D; Lee JJ
  • Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck.
    Volume: 92 Page(s): 2364 - 2373
    11/01/2001 Authors: Tseng JE; Glisson BS; Khuri FR; Shin DM; Myers JN; El-Naggar AK; Roach JS; Ginsberg LE; Thall PF; Wang X
  • A phase I study of continuous infusion of TNP-470 alone or in combination with paclitaxel and carboplatin in adult patients with solid tumors.
    CLINICAL CANCER RESEARCH Volume: 7 Page(s): 3659S - 3659S
    11/01/2001 Authors: Blumenschein GR; Fossella FV; Pisters KM; Shin DM; Khuri FR; Lu C; Kies MS; Glisson BS; Zinner RG; Schaerer R
  • Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development.
    Clin Cancer Res Volume: 7 Page(s): 3127 - 3134
    10/01/2001 Authors: Papadimitrakopoulou VA; Izzo J; Mao L; Keck J; Hamilton D; Shin DM; El-Naggar A; den Hollander P; Liu D; Hittelman WN
  • Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
    J Clin Oncol Volume: 19 Page(s): 3010 - 3017
    06/15/2001 Authors: Shin DM; Khuri FR; Murphy B; Garden AS; Clayman G; Francisco M; Liu D; Glisson BS; Ginsberg L; Papadimitrakopoulou V
  • p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis.
    Cancer Epidemiol Biomarkers Prev Volume: 10 Page(s): 603 - 609
    06/01/2001 Authors: Shin DM; Charuruks N; Lippman SM; Lee JJ; Ro JY; Hong WK; Hittelman WN
  • Recent advances in the management of squamous cell carcinoma of the head and neck.
    Expert Rev Anticancer Ther Volume: 1 Page(s): 99 - 110
    06/01/2001 Authors: Kim KB; Khuri FR; Shin DM
  • Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.
    J Clin Oncol Volume: 19 Page(s): 2626 - 2637
    05/15/2001 Authors: Khuri FR; Rigas JR; Figlin RA; Gralla RJ; Shin DM; Munden R; Fox N; Huyghe MR; Kean Y; Reich SD
  • Targeting growth factor receptors: integration of novel therapeutics in the management of head and neck cancer.
    Curr Opin Oncol Volume: 13 Page(s): 168 - 175
    05/01/2001 Authors: Lango MN; Shin DM; Grandis JR
  • Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer.
    Clin Cancer Res Volume: 7 Page(s): 1204 - 1213
    05/01/2001 Authors: Shin DM; Donato NJ; Perez-Soler R; Shin HJ; Wu JY; Zhang P; Lawhorn K; Khuri FR; Glisson BS; Myers J
  • Chromosome polysomy and histological characteristics in oral premalignant lesions.
    Cancer Epidemiol Biomarkers Prev Volume: 10 Page(s): 319 - 325
    04/01/2001 Authors: Kim J; Shin DM; El-Naggar A; Lee JS; Corrales C; Lippman SM; Hong WK; Hittelman WN
  • Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma.
    Cancer Volume: 91 Page(s): 1316 - 1323
    04/01/2001 Authors: Shin DM; Khuri FR; Glisson BS; Ginsberg L; Papadimitrakopoulou VM; Clayman G; Lee JJ; Ang KK; Lippman SM; Hong WK
  • Phase I trial of oral green tea extract in adult patients with solid tumors.
    J Clin Oncol Volume: 19 Page(s): 1830 - 1838
    03/15/2001 Authors: Pisters KM; Newman RA; Coldman B; Shin DM; Khuri FR; Hong WK; Glisson BS; Lee JS
  • Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck.
    J Clin Oncol Volume: 19 Page(s): 1096 - 1104
    02/15/2001 Authors: Posner MR; Glisson B; Frenette G; Al-Sarraf M; Colevas AD; Norris CM; Seroskie JD; Shin DM; Olivares R; Garay CA
  • Detection of numerical aberrations of chromosomes 7 and 9 in the effusion fluids of pleural malignant mesothelioma (MM).
    MODERN PATHOLOGY Volume: 14 Page(s): 61A - 61A
    01/01/2001 Authors: Shin HJC; Shin DM; Tarco E; Zhang P; Sneige N
  • Visualization of the timing of gene amplification during multistep head and neck tumorigenesis.
    Cancer Res Volume: 60 Page(s): 6496 - 6502
    11/15/2000 Authors: Roh HJ; Shin DM; Lee JS; Ro JY; Tainsky MA; Hong WK; Hittelman WN
  • MR imaging abnormality of the masticator muscles following intra-arterial chemotherapy for sinonasal malignancy: Tumor involvement or chemotoxicity?
    RADIOLOGY Volume: 217 Page(s): 474 - 474
    11/01/2000 Authors: Ginsberg LE; Chan L; Diaz EM; Shin DM
  • Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions.
    Semin Oncol Volume: 27 Page(s): 25 - 33
    08/01/2000 Authors: Khuri FR; Shin DM; Glisson BS; Lippman SM; Hong WK
  • Phase II study of intravenous Doxil in malignant pleural mesothelioma.
    Invest New Drugs Volume: 18 Page(s): 243 - 245
    08/01/2000 Authors: Oh Y; Perez-Soler R; Fossella FV; Glisson BS; Kurie J; Walsh GL; Truong M; Shin DM
  • Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis.
    Clin Cancer Res Volume: 6 Page(s): 2821 - 2828
    07/01/2000 Authors: Tae K; El-Naggar AK; Yoo E; Feng L; Lee JJ; Hong WK; Hittelman WN; Shin DM
  • Predicting cancer development in oral leukoplakia: ten years of translational research.
    Clin Cancer Res Volume: 6 Page(s): 1702 - 1710
    05/01/2000 Authors: Lee JJ; Hong WK; Hittelman WN; Mao L; Lotan R; Shin DM; Benner SE; Xu XC; Lee JS; Papadimitrakopoulou VM
  • Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53).
    Cancer Gene Ther Volume: 7 Page(s): 530 - 536
    04/01/2000 Authors: Yen N; Ioannides CG; Xu K; Swisher SG; Lawrence DD; Kemp BL; El-Naggar AK; Cristiano RJ; Fang B; Glisson BS
  • Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer.
    J Clin Oncol Volume: 18 Page(s): 609 - 622
    02/01/2000 Authors: Nemunaitis J; Swisher SG; Timmons T; Connors D; Mack M; Doerksen L; Weill D; Wait J; Lawrence DD; Kemp BL
  • Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    SEMINARS IN ONCOLOGY Volume: 27 Page(s): 36 - 40
    02/01/2000 Authors: Shin DM
  • Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Semin Oncol Volume: 27 Page(s): 36 - 40
    02/01/2000 Authors: Shin DM
  • Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression.
    J Natl Cancer Inst Volume: 92 Page(s): 69 - 73
    01/05/2000 Authors: Shin DM; Mao L; Papadimitrakopoulou VM; Clayman G; El-Naggar A; Shin HJ; Lee JJ; Lee JS; Gillenwater A; Myers J
  • Paclitaxel and ifosfamide-based chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck
    SEMINARS IN ONCOLOGY Volume: 26 Page(s): 59 - 59
    12/01/1999 Authors: Shin DM; Khuri FR; Glisson BS; Papadimitrakopoulou V; Ginsberg L; Lippman SM; Hong WK
  • Biochemoprevention for dysplastic aerodigestive tract lesions: effects of cyclin D1 and p16 abnormalities.
    CLINICAL CANCER RESEARCH Volume: 5 Page(s): 3866S - 3866S
    11/01/1999 Authors: Papadimitrakopoulou VA; Izzo J; Keck JM; Mao L; El-Naggar AK; Shin DM; Hittelman WN; Hong WK
  • Biochemoprevention for dysplastic lesions of the upper aerodigestive tract.
    Arch Otolaryngol Head Neck Surg Volume: 125 Page(s): 1083 - 1089
    10/01/1999 Authors: Papadimitrakopoulou VA; Clayman GL; Shin DM; Myers JN; Gillenwater AM; Goepfert H; El-Naggar AK; Lewin JS; Lippman SM; Hong WK
  • Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma.
    J Clin Oncol Volume: 17 Page(s): 2309 - 2315
    08/01/1999 Authors: Glisson BS; Kurie JM; Perez-Soler R; Fox NJ; Murphy WK; Fossella FV; Lee JS; Ross MB; Nyberg DA; Pisters KM
  • Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responses.
    J Clin Oncol Volume: 17 Page(s): 2390 - 2395
    08/01/1999 Authors: Garden AS; Glisson BS; Ang KK; Morrison WH; Lippman SM; Byers RM; Geara F; Clayman GL; Shin DM; Callender DL
  • Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer.
    J Natl Cancer Inst Volume: 91 Page(s): 763 - 771
    05/05/1999 Authors: Swisher SG; Roth JA; Nemunaitis J; Lawrence DD; Kemp BL; Carrasco CH; Connors DG; El-Naggar AK; Fossella F; Glisson BS
  • P53 expression and polysomies of chromosome 9, 17 in head and neck cancer prognosis.
    J Med Assoc Thai Volume: 82 Page(s): 466 - 476
    05/01/1999 Authors: Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
  • A pilot clinical laboratory trial of paclitaxel and endobronchial brachytherapy in patients with non-small cell lung cancer.
    Semin Radiat Oncol Volume: 9 Page(s): 121 - 129
    04/01/1999 Authors: Lee JS; Komaki R; Morice RC; Ro JY; Kalapurakal SK; Schea R; Murphy WK; Shin DM; Fox NT; Walsh GL
  • A pilot clinical laboratory trial of paclitaxel and endobronchial brachytherapy in patients with non-small cell lung cancer
    SEMINARS IN RADIATION ONCOLOGY Volume: 9 Page(s): 121 - 129
    04/01/1999 Authors: Lee JS; Komaki R; Morice RC; Ro JY; Kalapurakal SK; Schea R; Murphy WK; Shin DM; Fox NT; Walsh GL
  • Paclitaxel-based chemotherapy for recurrent and/or metastatic head and neck squamous cell carcinoma: current and future directions.
    Semin Oncol Volume: 26 Page(s): 100 - 105
    02/01/1999 Authors: Shin DM; Lippman SM
  • Paclitaxel, ifosfamide, and carboplatin (TIC) in patients with recurrent or metastatic head and neck cancer: Preliminary results
    SEMINARS IN ONCOLOGY Volume: 26 Page(s): 135 - 135
    02/01/1999 Authors: Shin DM; Khuri FR; Ginsberg L; Papadimitrakopoulou V; Glisson BS; Hong WK
  • Unusual presentation of mycosis fungoides as pigmented purpura with malignant thymoma
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY Volume: 39 Page(s): 858 - 863
    11/01/1998 Authors: Cather JC; Farmer A; Jackow C; Manning JT; Shin DM; Duvic M
  • Unusual presentation of mycosis fungoides as pigmented purpura with malignant thymoma.
    J Am Acad Dermatol Volume: 39 Page(s): 858 - 863
    11/01/1998 Authors: Cather JC; Farmer A; Jackow C; Manning JT; Shin DM; Duvic M
  • Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy.
    J Natl Cancer Inst Volume: 90 Page(s): 1545 - 1551
    10/21/1998 Authors: Mao L; El-Naggar AK; Papadimitrakopoulou V; Shin DM; Shin HC; Fan Y; Zhou X; Clayman G; Lee JJ; Lee JS
  • A multidisciplinary approach to therapy for unresectable malignant thymoma.
    Ann Intern Med Volume: 129 Page(s): 100 - 104
    07/15/1998 Authors: Shin DM; Walsh GL; Komaki R; Putnam JB; Nesbitt J; Ro JY; Shin HJ; Ki KH; Wimberly A; Pisters KM
  • Gene therapy for non-small cell lung cancer: A preliminary report of a phase I trial of adenoviral p53 gene replacement
    SEMINARS IN ONCOLOGY Volume: 25 Page(s): 33 - 37
    06/01/1998 Authors: Roth JA; Swisher SG; Merritt JA; Lawrence DD; Kemp BL; Carrasco CH; El-Naggar AK; Fossella FV; Glisson BS; Hong WK
  • Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement.
    Semin Oncol Volume: 25 Page(s): 33 - 37
    06/01/1998 Authors: Roth JA; Swisher SG; Merritt JA; Lawrence DD; Kemp BL; Carrasco CH; El-Naggar AK; Fossella FV; Glisson BS; Hong WK
  • Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    SEMINARS IN ONCOLOGY Volume: 25 Page(s): 40 - 44
    04/01/1998 Authors: Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
  • Phase II trial of recombinant IFN-alpha2a with etoposide/cisplatin induction and interferon/megestrol acetate maintenance in extensive small cell lung cancer.
    J Interferon Cytokine Res Volume: 18 Page(s): 241 - 245
    04/01/1998 Authors: Khuri FR; Fossella FV; Lee JS; Murphy WK; Shin DM; Markowitz AB; Glisson BS
  • Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Semin Oncol Volume: 25 Page(s): 40 - 44
    04/01/1998 Authors: Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
  • Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
    J Clin Oncol Volume: 16 Page(s): 1325 - 1330
    04/01/1998 Authors: Shin DM; Glisson BS; Khuri FR; Ginsberg L; Papadimitrakopoulou V; Lee JJ; Lawhorn K; Gillenwater AM; Ang KK; Clayman GL
  • Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study.
    Int J Radiat Oncol Biol Phys Volume: 40 Page(s): 331 - 336
    01/15/1998 Authors: Glisson B; Komaki R; Lee JS; Shin DM; Fossella F; Murphy WK; Kurie J; Perez-Soler R; Schea R; Vadhan-Raj S
  • Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
    Cancer Volume: 82 Page(s): 301 - 308
    01/15/1998 Authors: Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
  • Incidence and management of acute infusion reactions with the administration of Doxil (R)
    ANNALS OF ONCOLOGY Volume: 9 Page(s): 53 - 53
    01/01/1998 Authors: Perez-Soler R; Wimberly A; Blumenschein G; Logothetis C; Shin DM; Legha S
  • Phase I study of paclitaxel administered by ten-day continuous infusion.
    Invest New Drugs Volume: 16 Page(s): 237 - 243
    01/01/1998 Authors: Shade RJ; Pisters KM; Huber MH; Fossella F; Perez-Soler R; Shin DM; Kurie J; Glisson B; Lippman S; Lee JS
  • Recent advances in pacilitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck
    Volume: 24 Page(s): S33 - S37
    12/01/1997 Authors: Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
  • Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Semin Oncol Volume: 24 Page(s): S19-33-S19-37
    12/01/1997 Authors: Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
  • Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention.
    Clin Cancer Res Volume: 3 Page(s): 875 - 880
    06/01/1997 Authors: Shin DM; Xu XC; Lippman SM; Lee JJ; Lee JS; Batsakis JG; Ro JY; Martin JW; Hittelman WN; Lotan R
  • Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Clin Cancer Res Volume: 3 Page(s): 373 - 379
    03/01/1997 Authors: Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
  • Thymic neoplasms.
    Curr Opin Oncol Volume: 9 Page(s): 156 - 160
    03/01/1997 Authors: Komaki R; Putnam JB; Shin DM; Cox JD
  • Remission with carboplatin of paclitaxel resistant primary peritoneal papillary serous carcinoma: case report.
    Eur J Gynaecol Oncol Volume: 18 Page(s): 39 - 41
    01/01/1997 Authors: Herrada J; Kudelka AP; Tornos C; Shin DM; Kavanagh JJ; Edwards CL; Verschraegen CF
  • Biomarkers of squamous cell carcinoma of the head and neck.
    Histol Histopathol Volume: 12 Page(s): 205 - 218
    01/01/1997 Authors: Kim J; Shin DM
  • Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer.
    J Clin Oncol Volume: 15 Page(s): 310 - 316
    01/01/1997 Authors: Fossella FV; Lippman SM; Shin DM; Tarassoff P; Calayag-Jung M; Perez-Soler R; Lee JS; Murphy WK; Glisson B; Rivera E
  • Genetic instabilities of chromosome 9, 17 and accumulation of p53 overexpression during multistage tumorigesis in head and neck cancer.
    J Med Assoc Thai Volume: 79 Suppl 1 Page(s): S104 - S112
    12/01/1996 Authors: Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
  • Genetic instability and the development of recurrence of primary tumor and second primary tumor during head and neck tumorigenesis.
    J Med Assoc Thai Volume: 79 Suppl 1 Page(s): S49 - S55
    12/01/1996 Authors: Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
  • Biomarkers in airway tumors.
    Int J Oncol Volume: 9 Page(s): 1045 - 1053
    11/01/1996 Authors: Shin D; Hong W
  • Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan.
    J Clin Oncol Volume: 14 Page(s): 2785 - 2790
    10/01/1996 Authors: Perez-Soler R; Glisson BS; Lee JS; Fossella FV; Murphy WK; Shin DM; Hong WK
  • Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.
    Nat Med Volume: 2 Page(s): 985 - 991
    09/01/1996 Authors: Roth JA; Nguyen D; Lawrence DD; Kemp BL; Carrasco CH; Ferson DZ; Hong WK; Komaki R; Lee JJ; Nesbitt JC
  • p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma.
    J Natl Cancer Inst Volume: 88 Page(s): 519 - 529
    04/17/1996 Authors: Shin DM; Lee JS; Lippman SM; Lee JJ; Tu ZN; Choi G; Heyne K; Shin HJ; Ro JY; Goepfert H
  • Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis.
    Cancer Metastasis Rev Volume: 15 Page(s): 53 - 76
    03/01/1996 Authors: Papadimitrakopoulou VA; Shin DM; Hong WK
  • Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy.
    J Clin Oncol Volume: 14 Page(s): 503 - 513
    02/01/1996 Authors: Perez-Soler R; Fossella FV; Glisson BS; Lee JS; Murphy WK; Shin DM; Kemp BL; Lee JJ; Kane J; Robinson RA
  • Detection of chromosome instability of tissue fields at risk: in situ hybridization.
    J Cell Biochem Suppl Volume: 25 Page(s): 57 - 62
    01/01/1996 Authors: Hittelman WN; Kim HJ; Lee JS; Shin DM; Lippman SM; Kim J; Ro JY; Hong WK
  • Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
    Cancer Volume: 76 Page(s): 2230 - 2236
    12/01/1995 Authors: Shin DM; Fossella FV; Umsawasdi T; Murphy WK; Chasen MH; Walsh G; Komaki R; McMurtrey MJ; Hong WK
  • Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation.
    Int J Radiat Oncol Biol Phys Volume: 33 Page(s): 179 - 182
    08/30/1995 Authors: Komaki R; Meyers CA; Shin DM; Garden AS; Byrne K; Nickens JA; Cox JD
  • Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.
    J Clin Oncol Volume: 13 Page(s): 645 - 651
    03/01/1995 Authors: Fossella FV; Lee JS; Shin DM; Calayag M; Huber M; Perez-Soler R; Murphy WK; Lippman S; Benner S; Glisson B
  • Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer.
    Int J Radiat Oncol Biol Phys Volume: 31 Page(s): 807 - 811
    02/15/1995 Authors: Komaki R; Shin DM; Glisson BS; Fossella FV; Murphy WK; Garden AS; Oswald MJ; Hong WK; Roth JA; Peters LJ
  • p53 and retinoid chemoprevention of oral carcinogenesis.
    Cancer Res Volume: 55 Page(s): 16 - 19
    01/01/1995 Authors: Lippman SM; Shin DM; Lee JJ; Batsakis JG; Lotan R; Tainsky MA; Hittelman WN; Hong WK
  • Molecular phenotyping of head and neck cancer.
    Cancer Treat Res Volume: 74 Page(s): 17 - 42
    01/01/1995 Authors: Shin DM; Tainsky MA
  • Biomarkers in upper aerodigestive tract tumorigenesis: a review.
    Cancer Epidemiol Biomarkers Prev Volume: 3 Page(s): 697 - 709
    12/01/1994 Authors: Shin DM; Hittelman WN; Hong WK
  • Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues.
    Cancer Res Volume: 54 Page(s): 3580 - 3587
    07/01/1994 Authors: Xu XC; Ro JY; Lee JS; Shin DM; Hong WK; Lotan R
  • TUMOR EPIDERMAL GROWTH-FACTOR RECEPTOR STUDIES IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER OR HEAD AND NECK-CANCER TREATED WITH MONOCLONAL-ANTIBODY RG-83852 (VOL 12, PG 730, 1994)
    JOURNAL OF CLINICAL ONCOLOGY Volume: 12 Page(s): 1526 - 1526
    07/01/1994 Authors: PEREZSOLER R; DONATO NJ; SHIN DM; ROSENBLUM MG; ZHANG HZ; TORNOS C; BRENER H; CHAN JC; LEE JS; HONG WK
  • Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis.
    Cancer Res Volume: 54 Page(s): 3153 - 3159
    06/15/1994 Authors: Shin DM; Ro JY; Hong WK; Hittelman WN
  • Biomarkers in chemoprevention for upper aerodigestive tract tumors.
    Yonsei Med J Volume: 35 Page(s): 113 - 131
    06/01/1994 Authors: Shin DM; Ro JY; Hong WK
  • Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.
    J Clin Oncol Volume: 12 Page(s): 1238 - 1244
    06/01/1994 Authors: Fossella FV; Lee JS; Murphy WK; Lippman SM; Calayag M; Pang A; Chasen M; Shin DM; Glisson B; Benner S
  • Thymoma. A retrospective study of 87 cases.
    Cancer Volume: 73 Page(s): 2491 - 2498
    05/15/1994 Authors: Park HS; Shin DM; Lee JS; Komaki R; Pollack A; Putnam JB; Cox JD; Hong WK
  • Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852.
    J Clin Oncol Volume: 12 Page(s): 730 - 739
    04/01/1994 Authors: Perez-Soler R; Donato NJ; Shin DM; Rosenblum MG; Zhang HZ; Tornos C; Brewer H; Chan JC; Lee JS; Hong WK
  • OPTIMIZATION OF PROLIFERATING CELL NUCLEAR ANTIGEN IMMUNOHISTOCHEMICAL STAINING BY MICROWAVE-HEATING IN ZINC-SULFATE SOLUTION
    MODERN PATHOLOGY Volume: 7 Page(s): 242 - 248
    02/01/1994 Authors: SHIN HJC; SHIN DM; SHAH T; RO JY
  • Methods in pathology. Optimization of proliferating cell nuclear antigen immunohistochemical staining by microwave heating in zinc sulfate solution.
    Mod Pathol Volume: 7 Page(s): 242 - 248
    02/01/1994 Authors: Shin HJ; Shin DM; Shah T; Ro JY
  • Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis.
    Cancer Res Volume: 54 Page(s): 321 - 326
    01/15/1994 Authors: Shin DM; Kim J; Ro JY; Hittelman J; Roth JA; Hong WK; Hittelman WN
  • TEMPERATURE-DEPENDENT I-V CHARACTERISTICS AND THERMAL ANNEALING EFFECTS OF C-22-QUINOLIUM(TCNQ) LANGMUIR-BLODGETT-FILMS
    Volume: 247 Page(s): 233 - 242
    01/01/1994 Authors: KIM TW; SHIN DM; SONG IS; KANG DY; KWON YS
  • Phase II clinical trial of didemnin B in previously treated small cell lung cancer.
    Invest New Drugs Volume: 12 Page(s): 243 - 249
    01/01/1994 Authors: Shin DM; Holoye PY; Forman A; Winn R; Perez-Soler R; Dakhil S; Rosenthal J; Raber MN; Hong WK
  • P53 EXPRESSION IN PREMALIGNANT LESIONS DURING HEAD AND NECK TUMORIGENESIS
    LABORATORY INVESTIGATION Volume: 70 Page(s): A101 - A101
    01/01/1994 Authors: SHIN D; RO J; KIM J; HITTELMAN J; ROTH J; HONG W; HITTELMAN W
  • GENOMIC INSTABILITY AND P53 EXPRESSION IN BLADDER MULTISTEP TUMORIGENESIS
    LABORATORY INVESTIGATION Volume: 70 Page(s): A83 - A83
    01/01/1994 Authors: SHIN H; RO J; SHIN D; DHINGRA K; LOGOTHETIS C; AYALA A; BATSAKIS J; HITTELMAN W
  • Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker.
    J Natl Cancer Inst Volume: 85 Page(s): 971 - 978
    06/16/1993 Authors: Shin DM; Voravud N; Ro JY; Lee JS; Hong WK; Hittelman WN
  • Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis.
    Cancer Res Volume: 53 Page(s): 2874 - 2883
    06/15/1993 Authors: Voravud N; Shin DM; Ro JY; Lee JS; Hong WK; Hittelman WN
  • Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer.
    J Natl Cancer Inst Volume: 85 Page(s): 384 - 388
    03/03/1993 Authors: Murphy WK; Fossella FV; Winn RJ; Shin DM; Hynes HE; Gross HM; Davilla E; Leimert J; Dhingra H; Raber MN
  • Early genetic changes during upper aerodigestive tract tumorigenesis.
    J Cell Biochem Suppl Volume: 17F Page(s): 233 - 236
    01/01/1993 Authors: Hittelman WN; Voravud N; Shin DM; Lee JS; Ro JY; Hong WK
  • Activation of ribosomal protein S2 gene expression in a hamster model of chemically induced oral carcinogenesis.
    Carcinogenesis Volume: 14 Page(s): 163 - 166
    01/01/1993 Authors: Shin DM; Chiao PJ; Sacks PG; Shin HJ; Hong WK; Hittelman WN; Tainsky MA
  • INTERDIGITATING VERSUS CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY FOR LIMITED SMALL-CELL LUNG-CANCER (SCLC)
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 27 Page(s): 188 - 188
    01/01/1993 Authors: KOMAKI R; SHIN D; GLISSON B; FOSSELLA F; MURPHY W; GARDEN A; OSWALD M; HONG W; ROTH J; PETERS L
  • OPTIMIZATION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IMMUNOHISTOCHEMICAL STAINING BY MICROWAVE-OVEN HEATING (MWH) OF FORMALIN-FIXED, PARAFFIN-EMBEDDED (FFPE) TISSUE
    LABORATORY INVESTIGATION Volume: 68 Page(s): A140 - A140
    01/01/1993 Authors: SHIN H; SHIN D; SHAH T; RO J
  • Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer.
    J Natl Cancer Inst Volume: 84 Page(s): 1039 - 1040
    07/01/1992 Authors: Lee JS; Libshitz HI; Fossella FV; Murphy WK; Pang AC; Lippman SM; Shin DM; Dimery IW; Glisson BS; Hong WK
  • Implantation metastasis of carcinoma after percutaneous fine-needle aspiration biopsy.
    Chest Volume: 102 Page(s): 313 - 315
    07/01/1992 Authors: Voravud N; Shin DM; Dekmezian RH; Dimery I; Lee JS; Hong WK
  • Phase II study of combination therapy with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small-cell lung cancer.
    Am J Clin Oncol Volume: 15 Page(s): 194 - 199
    06/01/1992 Authors: Shin DM; Dhingra HM; Lee JS; Fossella FV; Murphy WK; Hong WK
  • Myotonia in patients treated for cancer with didemnin B.
    Muscle Nerve Volume: 15 Page(s): 515 - 517
    04/01/1992 Authors: Forman AD; Shin DM; Jackson R
  • Thymoma: treatment and prognosis.
    Int J Radiat Oncol Biol Phys Volume: 23 Page(s): 1037 - 1043
    01/01/1992 Authors: Pollack A; Komaki R; Cox JD; Ro JY; Oswald MJ; Shin DM; Putnam JB
  • Elevated expression of the ribosomal protein S2 gene in human tumors.
    Mol Carcinog Volume: 5 Page(s): 219 - 231
    01/01/1992 Authors: Chiao PJ; Shin DM; Sacks PG; Hong WK; Tainsky MA
  • Study of multidrug resistance (mdr1) gene in non-small-cell lung cancer.
    Anticancer Res Volume: 12 Page(s): 367 - 370
    01/01/1992 Authors: Shin HJ; Lee JS; Hong WK; Shin DM
  • Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer.
    Cancer Volume: 68 Page(s): 959 - 964
    09/01/1991 Authors: Lee JS; Libshitz HI; Fossella FV; Murphy WK; Pang AC; Lippman SM; Shin DM; Dimery IW; Glisson BS; Hong WK
  • Phase II clinical trial of 4'-O-tetrahydropyranyl-adriamycin (THP-adriamycin) in recurrent squamous cell carcinoma of the head and neck.
    Invest New Drugs Volume: 9 Page(s): 89 - 91
    02/01/1991 Authors: Shin DM; Kramer AM; Dimery IW; Raber MN; Ewer M; Hong WK
  • Simultaneous amplification of epidermal growth factor-receptor and multidrug-resistance genes in a newly. Established human lung cancer cell line.
    Anticancer Res Volume: 11 Page(s): 241 - 248
    01/01/1991 Authors: Shin HJ; Shin DM; Grant G; Hong WK; Pathak S
  • Phase I/II clinical trial of didemnin B in non-small-cell lung cancer: neuromuscular toxicity is dose-limiting.
    Cancer Chemother Pharmacol Volume: 29 Page(s): 145 - 149
    01/01/1991 Authors: Shin DM; Holoye PY; Murphy WK; Forman A; Papasozomenos SC; Hong WK; Raber M
  • Superior antiproliferative effects mediated by interferon-alpha entrapped in liposomes against a newly established human lung cancer cell line.
    J Biol Response Mod Volume: 9 Page(s): 355 - 360
    08/01/1990 Authors: Shin DM; Fidler IJ; Bucana CD; Fan D; Hong WK; Killion JJ
  • Changes in keratin expression during 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis.
    Cancer Res Volume: 50 Page(s): 4441 - 4445
    07/15/1990 Authors: Gimenez-Conti IB; Shin DM; Bianchi AB; Roop DR; Hong WK; Conti CJ; Slaga TJ
  • Expression of epidermal growth factor receptor, polyamine levels, ornithine decarboxylase activity, micronuclei, and transglutaminase I in a 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch carcinogenesis model.
    Cancer Res Volume: 50 Page(s): 2505 - 2510
    04/15/1990 Authors: Shin DM; Gimenez IB; Lee JS; Nishioka K; Wargovich MJ; Thacher S; Lotan R; Slaga TJ; Hong WK
  • Intrabronchial implantation of the Lewis lung tumor cell does not favor tumorigenicity and metastasis.
    Invasion Metastasis Volume: 10 Page(s): 129 - 141
    01/01/1990 Authors: Li LM; Shin DM; Fidler IJ
  • CYTOGENETIC CHANGES ASSOCIATED WITH SYRIAN-HAMSTER CHEEK POUCH TUMORIGENESIS INDUCED BY DMBA
    CANCER GENETICS AND CYTOGENETICS Volume: 41 Page(s): 251 - 251
    09/01/1989 Authors: CHEONG N; SOHN HY; SHIN D; HONG WK; HITTELMAN WN
  • Reduction to homozygosity at the SIS/PDGF-2 locus in human mesenchymal tumors.
    Biochem Biophys Res Commun Volume: 155 Page(s): 692 - 699
    09/15/1988 Authors: Shin DM; Ince C; Shtalrid M; Lee JS; Ro JS; Donner L; Ferrell RE; Hong WK; Wildrick D; Blick M
  • LOSS OF HETEROZYGOSITY OF SIS/PDGF-2 GENE IN HUMAN SARCOMAS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH Volume: 29 Page(s): 454 - 454
    03/01/1988 Authors: SHIN DM; INCE C; SHTALRID M; LEE JS; RO JS; HONG WK; FERREL RE; BLICK M
  • ONCOGENE EXPRESSION IN HUMAN-TUMORS OF SOFT-TISSUE AND BONE
    MODERN PATHOLOGY Volume: 1 Page(s): A36 - A36
    01/01/1988 Authors: GUPTA V; DONNER LR; SHIN DM; BLICK M
  • ONCOGENE EXPRESSION IN HUMAN-TUMORS OF SOFT-TISSUE AND BONE
    LABORATORY INVESTIGATION Volume: 58 Page(s): A36 - A36
    01/01/1988 Authors: GUPTA V; DONNER LR; SHIN DM; BLICK M; ANDERSON MD
  • ABERRANT EXPRESSION OF N-MYC AND C-K-RAS AS WELL AS OVEREXPRESSION OF C-SIS IN FRESH UNCULTURED HUMAN-MELANOMA SARCOMA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH Volume: 28 Page(s): 20 - 20
    03/01/1987 Authors: SHIN DM; GUPTA V; CHAWLA S; DONNER L; GUTTERMAN J; BLICK M
  • Aberrant oncogene expression in uncultured human sarcoma and melanoma.
    Anticancer Res Volume: 7 Page(s): 1117 - 1123
    01/01/1987 Authors: Shin DM; Gupta V; Donner L; Chawla S; Benjamin R; Gutterman J; Blick M
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements